Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n
\u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n
Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n
\u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n
After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n
Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n
\u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n
Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n
After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n
Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n
\u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n
Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n
After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n
Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n
\u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n
At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n
Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n
After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n
Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n
\u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
![\"\"](\"https:\/\/siliconvalley.center\/wp-content\/uploads\/2019\/12\/19237956_1506496169432016_7145519940911071151_o.jpg\")
<\/figure>\n\n\n\nThe next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n
At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n
Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n
After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n
Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n
\u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
\u201cIVC met three precision medicine startups,\u201d said consultant Cl?maco-Estardo. \u201cWith two of them they actually went on to have serious conversations.\u201d<\/p>\n\n\n\n Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
To help IVC address this issue we built a tour which included both introductions to startups operating in the precision health field and meetings at venture capital firms. This gave the vitamin maker an opportunity to explore partnerships and acquisitions which could help it keep up with and, eventually, get ahead of, the changes now taking place in its industry.<\/p>\n\n\n\n \u201cIVC met three precision medicine startups,\u201d said consultant Cl?maco-Estardo. \u201cWith two of them they actually went on to have serious conversations.\u201d<\/p>\n\n\n\n Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
\u201cMost young people don\u2019t take vitamins anymore. Mostly older people are taking vitamins. So the mentality has shifted.\u201d<\/p>\n\n\n\n To help IVC address this issue we built a tour which included both introductions to startups operating in the precision health field and meetings at venture capital firms. This gave the vitamin maker an opportunity to explore partnerships and acquisitions which could help it keep up with and, eventually, get ahead of, the changes now taking place in its industry.<\/p>\n\n\n\n \u201cIVC met three precision medicine startups,\u201d said consultant Cl?maco-Estardo. \u201cWith two of them they actually went on to have serious conversations.\u201d<\/p>\n\n\n\n Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
\u201cThis is something IVC are worried about,\u201d said Cl?maco-Estardo. \u201cIn the future, with DNA, people will know what kind of vitamins they need and don\u2019t need. That\u2019s a problem for the company.<\/p>\n\n\n\n \u201cMost young people don\u2019t take vitamins anymore. Mostly older people are taking vitamins. So the mentality has shifted.\u201d<\/p>\n\n\n\n To help IVC address this issue we built a tour which included both introductions to startups operating in the precision health field and meetings at venture capital firms. This gave the vitamin maker an opportunity to explore partnerships and acquisitions which could help it keep up with and, eventually, get ahead of, the changes now taking place in its industry.<\/p>\n\n\n\n \u201cIVC met three precision medicine startups,\u201d said consultant Cl?maco-Estardo. \u201cWith two of them they actually went on to have serious conversations.\u201d<\/p>\n\n\n\n Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
This is already being seen today in younger generations.<\/p>\n\n\n\n \u201cThis is something IVC are worried about,\u201d said Cl?maco-Estardo. \u201cIn the future, with DNA, people will know what kind of vitamins they need and don\u2019t need. That\u2019s a problem for the company.<\/p>\n\n\n\n \u201cMost young people don\u2019t take vitamins anymore. Mostly older people are taking vitamins. So the mentality has shifted.\u201d<\/p>\n\n\n\n To help IVC address this issue we built a tour which included both introductions to startups operating in the precision health field and meetings at venture capital firms. This gave the vitamin maker an opportunity to explore partnerships and acquisitions which could help it keep up with and, eventually, get ahead of, the changes now taking place in its industry.<\/p>\n\n\n\n \u201cIVC met three precision medicine startups,\u201d said consultant Cl?maco-Estardo. \u201cWith two of them they actually went on to have serious conversations.\u201d<\/p>\n\n\n\n Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
Among the most problematic market developments for IVC is the trend toward precision medicine whereby individuals, thanks to much greater access to their own personal health data, are deciding for themselves which treatments and pills they wish to take.<\/p>\n\n\n\n This is already being seen today in younger generations.<\/p>\n\n\n\n \u201cThis is something IVC are worried about,\u201d said Cl?maco-Estardo. \u201cIn the future, with DNA, people will know what kind of vitamins they need and don\u2019t need. That\u2019s a problem for the company.<\/p>\n\n\n\n \u201cMost young people don\u2019t take vitamins anymore. Mostly older people are taking vitamins. So the mentality has shifted.\u201d<\/p>\n\n\n\n To help IVC address this issue we built a tour which included both introductions to startups operating in the precision health field and meetings at venture capital firms. This gave the vitamin maker an opportunity to explore partnerships and acquisitions which could help it keep up with and, eventually, get ahead of, the changes now taking place in its industry.<\/p>\n\n\n\n \u201cIVC met three precision medicine startups,\u201d said consultant Cl?maco-Estardo. \u201cWith two of them they actually went on to have serious conversations.\u201d<\/p>\n\n\n\n Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
In the course of our more than 10 weeks of consultation with IVC we were able to distil the manufacturing company\u2019s long list of interests down to a concise list of priorities, each of which addressed a specific challenge facing its business.<\/p>\n\n\n\n Among the most problematic market developments for IVC is the trend toward precision medicine whereby individuals, thanks to much greater access to their own personal health data, are deciding for themselves which treatments and pills they wish to take.<\/p>\n\n\n\n This is already being seen today in younger generations.<\/p>\n\n\n\n \u201cThis is something IVC are worried about,\u201d said Cl?maco-Estardo. \u201cIn the future, with DNA, people will know what kind of vitamins they need and don\u2019t need. That\u2019s a problem for the company.<\/p>\n\n\n\n \u201cMost young people don\u2019t take vitamins anymore. Mostly older people are taking vitamins. So the mentality has shifted.\u201d<\/p>\n\n\n\n To help IVC address this issue we built a tour which included both introductions to startups operating in the precision health field and meetings at venture capital firms. This gave the vitamin maker an opportunity to explore partnerships and acquisitions which could help it keep up with and, eventually, get ahead of, the changes now taking place in its industry.<\/p>\n\n\n\n \u201cIVC met three precision medicine startups,\u201d said consultant Cl?maco-Estardo. \u201cWith two of them they actually went on to have serious conversations.\u201d<\/p>\n\n\n\n Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
In the course of our more than 10 weeks of consultation with IVC we were able to distil the manufacturing company\u2019s long list of interests down to a concise list of priorities, each of which addressed a specific challenge facing its business.<\/p>\n\n\n\n Among the most problematic market developments for IVC is the trend toward precision medicine whereby individuals, thanks to much greater access to their own personal health data, are deciding for themselves which treatments and pills they wish to take.<\/p>\n\n\n\n This is already being seen today in younger generations.<\/p>\n\n\n\n \u201cThis is something IVC are worried about,\u201d said Cl?maco-Estardo. \u201cIn the future, with DNA, people will know what kind of vitamins they need and don\u2019t need. That\u2019s a problem for the company.<\/p>\n\n\n\n \u201cMost young people don\u2019t take vitamins anymore. Mostly older people are taking vitamins. So the mentality has shifted.\u201d<\/p>\n\n\n\n To help IVC address this issue we built a tour which included both introductions to startups operating in the precision health field and meetings at venture capital firms. This gave the vitamin maker an opportunity to explore partnerships and acquisitions which could help it keep up with and, eventually, get ahead of, the changes now taking place in its industry.<\/p>\n\n\n\n \u201cIVC met three precision medicine startups,\u201d said consultant Cl?maco-Estardo. \u201cWith two of them they actually went on to have serious conversations.\u201d<\/p>\n\n\n\n Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
In the course of our more than 10 weeks of consultation with IVC we were able to distil the manufacturing company\u2019s long list of interests down to a concise list of priorities, each of which addressed a specific challenge facing its business.<\/p>\n\n\n\n Among the most problematic market developments for IVC is the trend toward precision medicine whereby individuals, thanks to much greater access to their own personal health data, are deciding for themselves which treatments and pills they wish to take.<\/p>\n\n\n\n This is already being seen today in younger generations.<\/p>\n\n\n\n \u201cThis is something IVC are worried about,\u201d said Cl?maco-Estardo. \u201cIn the future, with DNA, people will know what kind of vitamins they need and don\u2019t need. That\u2019s a problem for the company.<\/p>\n\n\n\n \u201cMost young people don\u2019t take vitamins anymore. Mostly older people are taking vitamins. So the mentality has shifted.\u201d<\/p>\n\n\n\n To help IVC address this issue we built a tour which included both introductions to startups operating in the precision health field and meetings at venture capital firms. This gave the vitamin maker an opportunity to explore partnerships and acquisitions which could help it keep up with and, eventually, get ahead of, the changes now taking place in its industry.<\/p>\n\n\n\n \u201cIVC met three precision medicine startups,\u201d said consultant Cl?maco-Estardo. \u201cWith two of them they actually went on to have serious conversations.\u201d<\/p>\n\n\n\n Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
\u201cThere are a lot of issues and a lot of technologies we can integrate,\u201d he said.<\/p>\n\n\n\n In the course of our more than 10 weeks of consultation with IVC we were able to distil the manufacturing company\u2019s long list of interests down to a concise list of priorities, each of which addressed a specific challenge facing its business.<\/p>\n\n\n\n Among the most problematic market developments for IVC is the trend toward precision medicine whereby individuals, thanks to much greater access to their own personal health data, are deciding for themselves which treatments and pills they wish to take.<\/p>\n\n\n\n This is already being seen today in younger generations.<\/p>\n\n\n\n \u201cThis is something IVC are worried about,\u201d said Cl?maco-Estardo. \u201cIn the future, with DNA, people will know what kind of vitamins they need and don\u2019t need. That\u2019s a problem for the company.<\/p>\n\n\n\n \u201cMost young people don\u2019t take vitamins anymore. Mostly older people are taking vitamins. So the mentality has shifted.\u201d<\/p>\n\n\n\n To help IVC address this issue we built a tour which included both introductions to startups operating in the precision health field and meetings at venture capital firms. This gave the vitamin maker an opportunity to explore partnerships and acquisitions which could help it keep up with and, eventually, get ahead of, the changes now taking place in its industry.<\/p>\n\n\n\n \u201cIVC met three precision medicine startups,\u201d said consultant Cl?maco-Estardo. \u201cWith two of them they actually went on to have serious conversations.\u201d<\/p>\n\n\n\n Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
Many of Cl?maco-Estardo\u2019s clients are in the manufacturing business, just like IVC. According to the consultant, it is an economic sector which is very much open to innovation and disruption.<\/p>\n\n\n\n \u201cThere are a lot of issues and a lot of technologies we can integrate,\u201d he said.<\/p>\n\n\n\n In the course of our more than 10 weeks of consultation with IVC we were able to distil the manufacturing company\u2019s long list of interests down to a concise list of priorities, each of which addressed a specific challenge facing its business.<\/p>\n\n\n\n Among the most problematic market developments for IVC is the trend toward precision medicine whereby individuals, thanks to much greater access to their own personal health data, are deciding for themselves which treatments and pills they wish to take.<\/p>\n\n\n\n This is already being seen today in younger generations.<\/p>\n\n\n\n \u201cThis is something IVC are worried about,\u201d said Cl?maco-Estardo. \u201cIn the future, with DNA, people will know what kind of vitamins they need and don\u2019t need. That\u2019s a problem for the company.<\/p>\n\n\n\n \u201cMost young people don\u2019t take vitamins anymore. Mostly older people are taking vitamins. So the mentality has shifted.\u201d<\/p>\n\n\n\n To help IVC address this issue we built a tour which included both introductions to startups operating in the precision health field and meetings at venture capital firms. This gave the vitamin maker an opportunity to explore partnerships and acquisitions which could help it keep up with and, eventually, get ahead of, the changes now taking place in its industry.<\/p>\n\n\n\n \u201cIVC met three precision medicine startups,\u201d said consultant Cl?maco-Estardo. \u201cWith two of them they actually went on to have serious conversations.\u201d<\/p>\n\n\n\n Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
\u201cI asked them what the key pain points are of their company,\u201d said Cl?maco-Estardo. \u201cMy questions revolve around what their issues are. That\u2019s when I integrate new companies and startups. Most of my programs are usually aligned to that.\u201d<\/p>\n\n\n\n Many of Cl?maco-Estardo\u2019s clients are in the manufacturing business, just like IVC. According to the consultant, it is an economic sector which is very much open to innovation and disruption.<\/p>\n\n\n\n \u201cThere are a lot of issues and a lot of technologies we can integrate,\u201d he said.<\/p>\n\n\n\n In the course of our more than 10 weeks of consultation with IVC we were able to distil the manufacturing company\u2019s long list of interests down to a concise list of priorities, each of which addressed a specific challenge facing its business.<\/p>\n\n\n\n Among the most problematic market developments for IVC is the trend toward precision medicine whereby individuals, thanks to much greater access to their own personal health data, are deciding for themselves which treatments and pills they wish to take.<\/p>\n\n\n\n This is already being seen today in younger generations.<\/p>\n\n\n\n \u201cThis is something IVC are worried about,\u201d said Cl?maco-Estardo. \u201cIn the future, with DNA, people will know what kind of vitamins they need and don\u2019t need. That\u2019s a problem for the company.<\/p>\n\n\n\n \u201cMost young people don\u2019t take vitamins anymore. Mostly older people are taking vitamins. So the mentality has shifted.\u201d<\/p>\n\n\n\n To help IVC address this issue we built a tour which included both introductions to startups operating in the precision health field and meetings at venture capital firms. This gave the vitamin maker an opportunity to explore partnerships and acquisitions which could help it keep up with and, eventually, get ahead of, the changes now taking place in its industry.<\/p>\n\n\n\n \u201cIVC met three precision medicine startups,\u201d said consultant Cl?maco-Estardo. \u201cWith two of them they actually went on to have serious conversations.\u201d<\/p>\n\n\n\n Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
Prior to the tour, our director of business development and corporate innovation Russel Cl?maco-Estardo spent some two and a half months in dialogue with the pill manufacturer\u2019s representatives in both China and the U.S. as he gradually built up an understanding of both what the company hoped to get out of the trip to California and, therefore, which Silicon Valley enterprises he should introduce it to.<\/p>\n\n\n\n \u201cI asked them what the key pain points are of their company,\u201d said Cl?maco-Estardo. \u201cMy questions revolve around what their issues are. That\u2019s when I integrate new companies and startups. Most of my programs are usually aligned to that.\u201d<\/p>\n\n\n\n Many of Cl?maco-Estardo\u2019s clients are in the manufacturing business, just like IVC. According to the consultant, it is an economic sector which is very much open to innovation and disruption.<\/p>\n\n\n\n \u201cThere are a lot of issues and a lot of technologies we can integrate,\u201d he said.<\/p>\n\n\n\n In the course of our more than 10 weeks of consultation with IVC we were able to distil the manufacturing company\u2019s long list of interests down to a concise list of priorities, each of which addressed a specific challenge facing its business.<\/p>\n\n\n\n Among the most problematic market developments for IVC is the trend toward precision medicine whereby individuals, thanks to much greater access to their own personal health data, are deciding for themselves which treatments and pills they wish to take.<\/p>\n\n\n\n This is already being seen today in younger generations.<\/p>\n\n\n\n \u201cThis is something IVC are worried about,\u201d said Cl?maco-Estardo. \u201cIn the future, with DNA, people will know what kind of vitamins they need and don\u2019t need. That\u2019s a problem for the company.<\/p>\n\n\n\n \u201cMost young people don\u2019t take vitamins anymore. Mostly older people are taking vitamins. So the mentality has shifted.\u201d<\/p>\n\n\n\n To help IVC address this issue we built a tour which included both introductions to startups operating in the precision health field and meetings at venture capital firms. This gave the vitamin maker an opportunity to explore partnerships and acquisitions which could help it keep up with and, eventually, get ahead of, the changes now taking place in its industry.<\/p>\n\n\n\n \u201cIVC met three precision medicine startups,\u201d said consultant Cl?maco-Estardo. \u201cWith two of them they actually went on to have serious conversations.\u201d<\/p>\n\n\n\n Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
Prior to the tour, our director of business development and corporate innovation Russel Cl?maco-Estardo spent some two and a half months in dialogue with the pill manufacturer\u2019s representatives in both China and the U.S. as he gradually built up an understanding of both what the company hoped to get out of the trip to California and, therefore, which Silicon Valley enterprises he should introduce it to.<\/p>\n\n\n\n \u201cI asked them what the key pain points are of their company,\u201d said Cl?maco-Estardo. \u201cMy questions revolve around what their issues are. That\u2019s when I integrate new companies and startups. Most of my programs are usually aligned to that.\u201d<\/p>\n\n\n\n Many of Cl?maco-Estardo\u2019s clients are in the manufacturing business, just like IVC. According to the consultant, it is an economic sector which is very much open to innovation and disruption.<\/p>\n\n\n\n \u201cThere are a lot of issues and a lot of technologies we can integrate,\u201d he said.<\/p>\n\n\n\n In the course of our more than 10 weeks of consultation with IVC we were able to distil the manufacturing company\u2019s long list of interests down to a concise list of priorities, each of which addressed a specific challenge facing its business.<\/p>\n\n\n\n Among the most problematic market developments for IVC is the trend toward precision medicine whereby individuals, thanks to much greater access to their own personal health data, are deciding for themselves which treatments and pills they wish to take.<\/p>\n\n\n\n This is already being seen today in younger generations.<\/p>\n\n\n\n \u201cThis is something IVC are worried about,\u201d said Cl?maco-Estardo. \u201cIn the future, with DNA, people will know what kind of vitamins they need and don\u2019t need. That\u2019s a problem for the company.<\/p>\n\n\n\n \u201cMost young people don\u2019t take vitamins anymore. Mostly older people are taking vitamins. So the mentality has shifted.\u201d<\/p>\n\n\n\n To help IVC address this issue we built a tour which included both introductions to startups operating in the precision health field and meetings at venture capital firms. This gave the vitamin maker an opportunity to explore partnerships and acquisitions which could help it keep up with and, eventually, get ahead of, the changes now taking place in its industry.<\/p>\n\n\n\n \u201cIVC met three precision medicine startups,\u201d said consultant Cl?maco-Estardo. \u201cWith two of them they actually went on to have serious conversations.\u201d<\/p>\n\n\n\n Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
An example of how this works can be seen in the case of International Vitamin Corporation (IVC), which recently toured Silicon Valley with our help.<\/em><\/p>\n\n\n\n Prior to the tour, our director of business development and corporate innovation Russel Cl?maco-Estardo spent some two and a half months in dialogue with the pill manufacturer\u2019s representatives in both China and the U.S. as he gradually built up an understanding of both what the company hoped to get out of the trip to California and, therefore, which Silicon Valley enterprises he should introduce it to.<\/p>\n\n\n\n \u201cI asked them what the key pain points are of their company,\u201d said Cl?maco-Estardo. \u201cMy questions revolve around what their issues are. That\u2019s when I integrate new companies and startups. Most of my programs are usually aligned to that.\u201d<\/p>\n\n\n\n Many of Cl?maco-Estardo\u2019s clients are in the manufacturing business, just like IVC. According to the consultant, it is an economic sector which is very much open to innovation and disruption.<\/p>\n\n\n\n \u201cThere are a lot of issues and a lot of technologies we can integrate,\u201d he said.<\/p>\n\n\n\n In the course of our more than 10 weeks of consultation with IVC we were able to distil the manufacturing company\u2019s long list of interests down to a concise list of priorities, each of which addressed a specific challenge facing its business.<\/p>\n\n\n\n Among the most problematic market developments for IVC is the trend toward precision medicine whereby individuals, thanks to much greater access to their own personal health data, are deciding for themselves which treatments and pills they wish to take.<\/p>\n\n\n\n This is already being seen today in younger generations.<\/p>\n\n\n\n \u201cThis is something IVC are worried about,\u201d said Cl?maco-Estardo. \u201cIn the future, with DNA, people will know what kind of vitamins they need and don\u2019t need. That\u2019s a problem for the company.<\/p>\n\n\n\n \u201cMost young people don\u2019t take vitamins anymore. Mostly older people are taking vitamins. So the mentality has shifted.\u201d<\/p>\n\n\n\n To help IVC address this issue we built a tour which included both introductions to startups operating in the precision health field and meetings at venture capital firms. This gave the vitamin maker an opportunity to explore partnerships and acquisitions which could help it keep up with and, eventually, get ahead of, the changes now taking place in its industry.<\/p>\n\n\n\n \u201cIVC met three precision medicine startups,\u201d said consultant Cl?maco-Estardo. \u201cWith two of them they actually went on to have serious conversations.\u201d<\/p>\n\n\n\n Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
At Silicon Valley Innovation Center (SVIC) \u201csuccess\u201d does not simply equate to selling a client a tour of Silicon Valley. What it actually comes down to is creating a tour which enables them to find solutions to the major challenges they face in their business. <\/em>Outcomes of that sort come about not as a matter luck but rather as a result of a painstaking investigate process which involves working closely with our clients in order to elicit a clear articulation of the problems they want to solve.<\/em><\/p>\n\n\n\n An example of how this works can be seen in the case of International Vitamin Corporation (IVC), which recently toured Silicon Valley with our help.<\/em><\/p>\n\n\n\n Prior to the tour, our director of business development and corporate innovation Russel Cl?maco-Estardo spent some two and a half months in dialogue with the pill manufacturer\u2019s representatives in both China and the U.S. as he gradually built up an understanding of both what the company hoped to get out of the trip to California and, therefore, which Silicon Valley enterprises he should introduce it to.<\/p>\n\n\n\n \u201cI asked them what the key pain points are of their company,\u201d said Cl?maco-Estardo. \u201cMy questions revolve around what their issues are. That\u2019s when I integrate new companies and startups. Most of my programs are usually aligned to that.\u201d<\/p>\n\n\n\n Many of Cl?maco-Estardo\u2019s clients are in the manufacturing business, just like IVC. According to the consultant, it is an economic sector which is very much open to innovation and disruption.<\/p>\n\n\n\n \u201cThere are a lot of issues and a lot of technologies we can integrate,\u201d he said.<\/p>\n\n\n\n In the course of our more than 10 weeks of consultation with IVC we were able to distil the manufacturing company\u2019s long list of interests down to a concise list of priorities, each of which addressed a specific challenge facing its business.<\/p>\n\n\n\n Among the most problematic market developments for IVC is the trend toward precision medicine whereby individuals, thanks to much greater access to their own personal health data, are deciding for themselves which treatments and pills they wish to take.<\/p>\n\n\n\n This is already being seen today in younger generations.<\/p>\n\n\n\n \u201cThis is something IVC are worried about,\u201d said Cl?maco-Estardo. \u201cIn the future, with DNA, people will know what kind of vitamins they need and don\u2019t need. That\u2019s a problem for the company.<\/p>\n\n\n\n \u201cMost young people don\u2019t take vitamins anymore. Mostly older people are taking vitamins. So the mentality has shifted.\u201d<\/p>\n\n\n\n To help IVC address this issue we built a tour which included both introductions to startups operating in the precision health field and meetings at venture capital firms. This gave the vitamin maker an opportunity to explore partnerships and acquisitions which could help it keep up with and, eventually, get ahead of, the changes now taking place in its industry.<\/p>\n\n\n\n \u201cIVC met three precision medicine startups,\u201d said consultant Cl?maco-Estardo. \u201cWith two of them they actually went on to have serious conversations.\u201d<\/p>\n\n\n\n Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
Silicon Valley Innovation Center supports this mission for a better tomorrow by helping corporations discover and partner with life science startups in Silicon Valley. To find out more about how you can visit Silicon Valley and experience, first hand, the breathtaking life science innovations emerging in the area, click here<\/a> or call us on +1 (650) 274-0214<\/a> to speak to an SVIC innovation tour specialist.<\/p>\n","post_title":"Overcoming Commercialization Challenges in Life Science Innovation","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"overcoming-commercialization-challenges-in-life-science-innovation","to_ping":"","pinged":"","post_modified":"2020-02-08 15:02:33","post_modified_gmt":"2020-02-08 23:02:33","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/overcoming-commercialization-challenges-in-life-science-innovation\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":764,"post_author":"1","post_date":"2018-04-17 14:51:00","post_date_gmt":"2018-04-17 21:51:00","post_content":"\n At Silicon Valley Innovation Center (SVIC) \u201csuccess\u201d does not simply equate to selling a client a tour of Silicon Valley. What it actually comes down to is creating a tour which enables them to find solutions to the major challenges they face in their business. <\/em>Outcomes of that sort come about not as a matter luck but rather as a result of a painstaking investigate process which involves working closely with our clients in order to elicit a clear articulation of the problems they want to solve.<\/em><\/p>\n\n\n\n An example of how this works can be seen in the case of International Vitamin Corporation (IVC), which recently toured Silicon Valley with our help.<\/em><\/p>\n\n\n\n Prior to the tour, our director of business development and corporate innovation Russel Cl?maco-Estardo spent some two and a half months in dialogue with the pill manufacturer\u2019s representatives in both China and the U.S. as he gradually built up an understanding of both what the company hoped to get out of the trip to California and, therefore, which Silicon Valley enterprises he should introduce it to.<\/p>\n\n\n\n \u201cI asked them what the key pain points are of their company,\u201d said Cl?maco-Estardo. \u201cMy questions revolve around what their issues are. That\u2019s when I integrate new companies and startups. Most of my programs are usually aligned to that.\u201d<\/p>\n\n\n\n Many of Cl?maco-Estardo\u2019s clients are in the manufacturing business, just like IVC. According to the consultant, it is an economic sector which is very much open to innovation and disruption.<\/p>\n\n\n\n \u201cThere are a lot of issues and a lot of technologies we can integrate,\u201d he said.<\/p>\n\n\n\n In the course of our more than 10 weeks of consultation with IVC we were able to distil the manufacturing company\u2019s long list of interests down to a concise list of priorities, each of which addressed a specific challenge facing its business.<\/p>\n\n\n\n Among the most problematic market developments for IVC is the trend toward precision medicine whereby individuals, thanks to much greater access to their own personal health data, are deciding for themselves which treatments and pills they wish to take.<\/p>\n\n\n\n This is already being seen today in younger generations.<\/p>\n\n\n\n \u201cThis is something IVC are worried about,\u201d said Cl?maco-Estardo. \u201cIn the future, with DNA, people will know what kind of vitamins they need and don\u2019t need. That\u2019s a problem for the company.<\/p>\n\n\n\n \u201cMost young people don\u2019t take vitamins anymore. Mostly older people are taking vitamins. So the mentality has shifted.\u201d<\/p>\n\n\n\n To help IVC address this issue we built a tour which included both introductions to startups operating in the precision health field and meetings at venture capital firms. This gave the vitamin maker an opportunity to explore partnerships and acquisitions which could help it keep up with and, eventually, get ahead of, the changes now taking place in its industry.<\/p>\n\n\n\n \u201cIVC met three precision medicine startups,\u201d said consultant Cl?maco-Estardo. \u201cWith two of them they actually went on to have serious conversations.\u201d<\/p>\n\n\n\n Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
But if this promise of a better tomorrow is to be realized, corporations must be willing to take the bold step of partnering with startups, many of which are pursuing \u201cmoonshot\u201d ideas in the hope of creating the life tools of tomorrow.<\/p>\n\n\n\n Silicon Valley Innovation Center supports this mission for a better tomorrow by helping corporations discover and partner with life science startups in Silicon Valley. To find out more about how you can visit Silicon Valley and experience, first hand, the breathtaking life science innovations emerging in the area, click here<\/a> or call us on +1 (650) 274-0214<\/a> to speak to an SVIC innovation tour specialist.<\/p>\n","post_title":"Overcoming Commercialization Challenges in Life Science Innovation","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"overcoming-commercialization-challenges-in-life-science-innovation","to_ping":"","pinged":"","post_modified":"2020-02-08 15:02:33","post_modified_gmt":"2020-02-08 23:02:33","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/overcoming-commercialization-challenges-in-life-science-innovation\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":764,"post_author":"1","post_date":"2018-04-17 14:51:00","post_date_gmt":"2018-04-17 21:51:00","post_content":"\n At Silicon Valley Innovation Center (SVIC) \u201csuccess\u201d does not simply equate to selling a client a tour of Silicon Valley. What it actually comes down to is creating a tour which enables them to find solutions to the major challenges they face in their business. <\/em>Outcomes of that sort come about not as a matter luck but rather as a result of a painstaking investigate process which involves working closely with our clients in order to elicit a clear articulation of the problems they want to solve.<\/em><\/p>\n\n\n\n An example of how this works can be seen in the case of International Vitamin Corporation (IVC), which recently toured Silicon Valley with our help.<\/em><\/p>\n\n\n\n Prior to the tour, our director of business development and corporate innovation Russel Cl?maco-Estardo spent some two and a half months in dialogue with the pill manufacturer\u2019s representatives in both China and the U.S. as he gradually built up an understanding of both what the company hoped to get out of the trip to California and, therefore, which Silicon Valley enterprises he should introduce it to.<\/p>\n\n\n\n \u201cI asked them what the key pain points are of their company,\u201d said Cl?maco-Estardo. \u201cMy questions revolve around what their issues are. That\u2019s when I integrate new companies and startups. Most of my programs are usually aligned to that.\u201d<\/p>\n\n\n\n Many of Cl?maco-Estardo\u2019s clients are in the manufacturing business, just like IVC. According to the consultant, it is an economic sector which is very much open to innovation and disruption.<\/p>\n\n\n\n \u201cThere are a lot of issues and a lot of technologies we can integrate,\u201d he said.<\/p>\n\n\n\n In the course of our more than 10 weeks of consultation with IVC we were able to distil the manufacturing company\u2019s long list of interests down to a concise list of priorities, each of which addressed a specific challenge facing its business.<\/p>\n\n\n\n Among the most problematic market developments for IVC is the trend toward precision medicine whereby individuals, thanks to much greater access to their own personal health data, are deciding for themselves which treatments and pills they wish to take.<\/p>\n\n\n\n This is already being seen today in younger generations.<\/p>\n\n\n\n \u201cThis is something IVC are worried about,\u201d said Cl?maco-Estardo. \u201cIn the future, with DNA, people will know what kind of vitamins they need and don\u2019t need. That\u2019s a problem for the company.<\/p>\n\n\n\n \u201cMost young people don\u2019t take vitamins anymore. Mostly older people are taking vitamins. So the mentality has shifted.\u201d<\/p>\n\n\n\n To help IVC address this issue we built a tour which included both introductions to startups operating in the precision health field and meetings at venture capital firms. This gave the vitamin maker an opportunity to explore partnerships and acquisitions which could help it keep up with and, eventually, get ahead of, the changes now taking place in its industry.<\/p>\n\n\n\n \u201cIVC met three precision medicine startups,\u201d said consultant Cl?maco-Estardo. \u201cWith two of them they actually went on to have serious conversations.\u201d<\/p>\n\n\n\n Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
\u201cThe involvement of technology to support life science will enable so many more innovations, ideas and also products for the lives of many more people and patients around the world,\u201d concludes Widya, a statement that reflects the efforts of so many life science practitioners and startups.<\/p>\n\n\n\n But if this promise of a better tomorrow is to be realized, corporations must be willing to take the bold step of partnering with startups, many of which are pursuing \u201cmoonshot\u201d ideas in the hope of creating the life tools of tomorrow.<\/p>\n\n\n\n Silicon Valley Innovation Center supports this mission for a better tomorrow by helping corporations discover and partner with life science startups in Silicon Valley. To find out more about how you can visit Silicon Valley and experience, first hand, the breathtaking life science innovations emerging in the area, click here<\/a> or call us on +1 (650) 274-0214<\/a> to speak to an SVIC innovation tour specialist.<\/p>\n","post_title":"Overcoming Commercialization Challenges in Life Science Innovation","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"overcoming-commercialization-challenges-in-life-science-innovation","to_ping":"","pinged":"","post_modified":"2020-02-08 15:02:33","post_modified_gmt":"2020-02-08 23:02:33","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/overcoming-commercialization-challenges-in-life-science-innovation\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":764,"post_author":"1","post_date":"2018-04-17 14:51:00","post_date_gmt":"2018-04-17 21:51:00","post_content":"\n At Silicon Valley Innovation Center (SVIC) \u201csuccess\u201d does not simply equate to selling a client a tour of Silicon Valley. What it actually comes down to is creating a tour which enables them to find solutions to the major challenges they face in their business. <\/em>Outcomes of that sort come about not as a matter luck but rather as a result of a painstaking investigate process which involves working closely with our clients in order to elicit a clear articulation of the problems they want to solve.<\/em><\/p>\n\n\n\n An example of how this works can be seen in the case of International Vitamin Corporation (IVC), which recently toured Silicon Valley with our help.<\/em><\/p>\n\n\n\n Prior to the tour, our director of business development and corporate innovation Russel Cl?maco-Estardo spent some two and a half months in dialogue with the pill manufacturer\u2019s representatives in both China and the U.S. as he gradually built up an understanding of both what the company hoped to get out of the trip to California and, therefore, which Silicon Valley enterprises he should introduce it to.<\/p>\n\n\n\n \u201cI asked them what the key pain points are of their company,\u201d said Cl?maco-Estardo. \u201cMy questions revolve around what their issues are. That\u2019s when I integrate new companies and startups. Most of my programs are usually aligned to that.\u201d<\/p>\n\n\n\n Many of Cl?maco-Estardo\u2019s clients are in the manufacturing business, just like IVC. According to the consultant, it is an economic sector which is very much open to innovation and disruption.<\/p>\n\n\n\n \u201cThere are a lot of issues and a lot of technologies we can integrate,\u201d he said.<\/p>\n\n\n\n In the course of our more than 10 weeks of consultation with IVC we were able to distil the manufacturing company\u2019s long list of interests down to a concise list of priorities, each of which addressed a specific challenge facing its business.<\/p>\n\n\n\n Among the most problematic market developments for IVC is the trend toward precision medicine whereby individuals, thanks to much greater access to their own personal health data, are deciding for themselves which treatments and pills they wish to take.<\/p>\n\n\n\n This is already being seen today in younger generations.<\/p>\n\n\n\n \u201cThis is something IVC are worried about,\u201d said Cl?maco-Estardo. \u201cIn the future, with DNA, people will know what kind of vitamins they need and don\u2019t need. That\u2019s a problem for the company.<\/p>\n\n\n\n \u201cMost young people don\u2019t take vitamins anymore. Mostly older people are taking vitamins. So the mentality has shifted.\u201d<\/p>\n\n\n\n To help IVC address this issue we built a tour which included both introductions to startups operating in the precision health field and meetings at venture capital firms. This gave the vitamin maker an opportunity to explore partnerships and acquisitions which could help it keep up with and, eventually, get ahead of, the changes now taking place in its industry.<\/p>\n\n\n\n \u201cIVC met three precision medicine startups,\u201d said consultant Cl?maco-Estardo. \u201cWith two of them they actually went on to have serious conversations.\u201d<\/p>\n\n\n\n Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
\u201cThe involvement of technology to support life science will enable so many more innovations, ideas and also products for the lives of many more people and patients around the world,\u201d concludes Widya, a statement that reflects the efforts of so many life science practitioners and startups.<\/p>\n\n\n\n But if this promise of a better tomorrow is to be realized, corporations must be willing to take the bold step of partnering with startups, many of which are pursuing \u201cmoonshot\u201d ideas in the hope of creating the life tools of tomorrow.<\/p>\n\n\n\n Silicon Valley Innovation Center supports this mission for a better tomorrow by helping corporations discover and partner with life science startups in Silicon Valley. To find out more about how you can visit Silicon Valley and experience, first hand, the breathtaking life science innovations emerging in the area, click here<\/a> or call us on +1 (650) 274-0214<\/a> to speak to an SVIC innovation tour specialist.<\/p>\n","post_title":"Overcoming Commercialization Challenges in Life Science Innovation","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"overcoming-commercialization-challenges-in-life-science-innovation","to_ping":"","pinged":"","post_modified":"2020-02-08 15:02:33","post_modified_gmt":"2020-02-08 23:02:33","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/overcoming-commercialization-challenges-in-life-science-innovation\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":764,"post_author":"1","post_date":"2018-04-17 14:51:00","post_date_gmt":"2018-04-17 21:51:00","post_content":"\n At Silicon Valley Innovation Center (SVIC) \u201csuccess\u201d does not simply equate to selling a client a tour of Silicon Valley. What it actually comes down to is creating a tour which enables them to find solutions to the major challenges they face in their business. <\/em>Outcomes of that sort come about not as a matter luck but rather as a result of a painstaking investigate process which involves working closely with our clients in order to elicit a clear articulation of the problems they want to solve.<\/em><\/p>\n\n\n\n An example of how this works can be seen in the case of International Vitamin Corporation (IVC), which recently toured Silicon Valley with our help.<\/em><\/p>\n\n\n\n Prior to the tour, our director of business development and corporate innovation Russel Cl?maco-Estardo spent some two and a half months in dialogue with the pill manufacturer\u2019s representatives in both China and the U.S. as he gradually built up an understanding of both what the company hoped to get out of the trip to California and, therefore, which Silicon Valley enterprises he should introduce it to.<\/p>\n\n\n\n \u201cI asked them what the key pain points are of their company,\u201d said Cl?maco-Estardo. \u201cMy questions revolve around what their issues are. That\u2019s when I integrate new companies and startups. Most of my programs are usually aligned to that.\u201d<\/p>\n\n\n\n Many of Cl?maco-Estardo\u2019s clients are in the manufacturing business, just like IVC. According to the consultant, it is an economic sector which is very much open to innovation and disruption.<\/p>\n\n\n\n \u201cThere are a lot of issues and a lot of technologies we can integrate,\u201d he said.<\/p>\n\n\n\n In the course of our more than 10 weeks of consultation with IVC we were able to distil the manufacturing company\u2019s long list of interests down to a concise list of priorities, each of which addressed a specific challenge facing its business.<\/p>\n\n\n\n Among the most problematic market developments for IVC is the trend toward precision medicine whereby individuals, thanks to much greater access to their own personal health data, are deciding for themselves which treatments and pills they wish to take.<\/p>\n\n\n\n This is already being seen today in younger generations.<\/p>\n\n\n\n \u201cThis is something IVC are worried about,\u201d said Cl?maco-Estardo. \u201cIn the future, with DNA, people will know what kind of vitamins they need and don\u2019t need. That\u2019s a problem for the company.<\/p>\n\n\n\n \u201cMost young people don\u2019t take vitamins anymore. Mostly older people are taking vitamins. So the mentality has shifted.\u201d<\/p>\n\n\n\n To help IVC address this issue we built a tour which included both introductions to startups operating in the precision health field and meetings at venture capital firms. This gave the vitamin maker an opportunity to explore partnerships and acquisitions which could help it keep up with and, eventually, get ahead of, the changes now taking place in its industry.<\/p>\n\n\n\n \u201cIVC met three precision medicine startups,\u201d said consultant Cl?maco-Estardo. \u201cWith two of them they actually went on to have serious conversations.\u201d<\/p>\n\n\n\n Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
Through this acquisition, Varian, previously stuck incrementally improving existing products, now has an entirely new line of products. Along these lines, Widya says, corporations need to seek out partnerships with innovative Silicon Valley startups, a move that can help them generate new capabilities without the lengthy and expensive process of creating such innovations in-house.<\/p>\n\n\n\n \u201cThe involvement of technology to support life science will enable so many more innovations, ideas and also products for the lives of many more people and patients around the world,\u201d concludes Widya, a statement that reflects the efforts of so many life science practitioners and startups.<\/p>\n\n\n\n But if this promise of a better tomorrow is to be realized, corporations must be willing to take the bold step of partnering with startups, many of which are pursuing \u201cmoonshot\u201d ideas in the hope of creating the life tools of tomorrow.<\/p>\n\n\n\n Silicon Valley Innovation Center supports this mission for a better tomorrow by helping corporations discover and partner with life science startups in Silicon Valley. To find out more about how you can visit Silicon Valley and experience, first hand, the breathtaking life science innovations emerging in the area, click here<\/a> or call us on +1 (650) 274-0214<\/a> to speak to an SVIC innovation tour specialist.<\/p>\n","post_title":"Overcoming Commercialization Challenges in Life Science Innovation","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"overcoming-commercialization-challenges-in-life-science-innovation","to_ping":"","pinged":"","post_modified":"2020-02-08 15:02:33","post_modified_gmt":"2020-02-08 23:02:33","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/overcoming-commercialization-challenges-in-life-science-innovation\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":764,"post_author":"1","post_date":"2018-04-17 14:51:00","post_date_gmt":"2018-04-17 21:51:00","post_content":"\n At Silicon Valley Innovation Center (SVIC) \u201csuccess\u201d does not simply equate to selling a client a tour of Silicon Valley. What it actually comes down to is creating a tour which enables them to find solutions to the major challenges they face in their business. <\/em>Outcomes of that sort come about not as a matter luck but rather as a result of a painstaking investigate process which involves working closely with our clients in order to elicit a clear articulation of the problems they want to solve.<\/em><\/p>\n\n\n\n An example of how this works can be seen in the case of International Vitamin Corporation (IVC), which recently toured Silicon Valley with our help.<\/em><\/p>\n\n\n\n Prior to the tour, our director of business development and corporate innovation Russel Cl?maco-Estardo spent some two and a half months in dialogue with the pill manufacturer\u2019s representatives in both China and the U.S. as he gradually built up an understanding of both what the company hoped to get out of the trip to California and, therefore, which Silicon Valley enterprises he should introduce it to.<\/p>\n\n\n\n \u201cI asked them what the key pain points are of their company,\u201d said Cl?maco-Estardo. \u201cMy questions revolve around what their issues are. That\u2019s when I integrate new companies and startups. Most of my programs are usually aligned to that.\u201d<\/p>\n\n\n\n Many of Cl?maco-Estardo\u2019s clients are in the manufacturing business, just like IVC. According to the consultant, it is an economic sector which is very much open to innovation and disruption.<\/p>\n\n\n\n \u201cThere are a lot of issues and a lot of technologies we can integrate,\u201d he said.<\/p>\n\n\n\n In the course of our more than 10 weeks of consultation with IVC we were able to distil the manufacturing company\u2019s long list of interests down to a concise list of priorities, each of which addressed a specific challenge facing its business.<\/p>\n\n\n\n Among the most problematic market developments for IVC is the trend toward precision medicine whereby individuals, thanks to much greater access to their own personal health data, are deciding for themselves which treatments and pills they wish to take.<\/p>\n\n\n\n This is already being seen today in younger generations.<\/p>\n\n\n\n \u201cThis is something IVC are worried about,\u201d said Cl?maco-Estardo. \u201cIn the future, with DNA, people will know what kind of vitamins they need and don\u2019t need. That\u2019s a problem for the company.<\/p>\n\n\n\n \u201cMost young people don\u2019t take vitamins anymore. Mostly older people are taking vitamins. So the mentality has shifted.\u201d<\/p>\n\n\n\n To help IVC address this issue we built a tour which included both introductions to startups operating in the precision health field and meetings at venture capital firms. This gave the vitamin maker an opportunity to explore partnerships and acquisitions which could help it keep up with and, eventually, get ahead of, the changes now taking place in its industry.<\/p>\n\n\n\n \u201cIVC met three precision medicine startups,\u201d said consultant Cl?maco-Estardo. \u201cWith two of them they actually went on to have serious conversations.\u201d<\/p>\n\n\n\n Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
The solution to faster life science innovation lies in corporations and startups collaborating more. One example of such a collaboration is the recent acquisition of Noona, a healthcare startup, by Varian, one of the largest radiation oncology treatments and software makers in the US.<\/p>\n\n\n\n Through this acquisition, Varian, previously stuck incrementally improving existing products, now has an entirely new line of products. Along these lines, Widya says, corporations need to seek out partnerships with innovative Silicon Valley startups, a move that can help them generate new capabilities without the lengthy and expensive process of creating such innovations in-house.<\/p>\n\n\n\n \u201cThe involvement of technology to support life science will enable so many more innovations, ideas and also products for the lives of many more people and patients around the world,\u201d concludes Widya, a statement that reflects the efforts of so many life science practitioners and startups.<\/p>\n\n\n\n But if this promise of a better tomorrow is to be realized, corporations must be willing to take the bold step of partnering with startups, many of which are pursuing \u201cmoonshot\u201d ideas in the hope of creating the life tools of tomorrow.<\/p>\n\n\n\n Silicon Valley Innovation Center supports this mission for a better tomorrow by helping corporations discover and partner with life science startups in Silicon Valley. To find out more about how you can visit Silicon Valley and experience, first hand, the breathtaking life science innovations emerging in the area, click here<\/a> or call us on +1 (650) 274-0214<\/a> to speak to an SVIC innovation tour specialist.<\/p>\n","post_title":"Overcoming Commercialization Challenges in Life Science Innovation","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"overcoming-commercialization-challenges-in-life-science-innovation","to_ping":"","pinged":"","post_modified":"2020-02-08 15:02:33","post_modified_gmt":"2020-02-08 23:02:33","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/overcoming-commercialization-challenges-in-life-science-innovation\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":764,"post_author":"1","post_date":"2018-04-17 14:51:00","post_date_gmt":"2018-04-17 21:51:00","post_content":"\n At Silicon Valley Innovation Center (SVIC) \u201csuccess\u201d does not simply equate to selling a client a tour of Silicon Valley. What it actually comes down to is creating a tour which enables them to find solutions to the major challenges they face in their business. <\/em>Outcomes of that sort come about not as a matter luck but rather as a result of a painstaking investigate process which involves working closely with our clients in order to elicit a clear articulation of the problems they want to solve.<\/em><\/p>\n\n\n\n An example of how this works can be seen in the case of International Vitamin Corporation (IVC), which recently toured Silicon Valley with our help.<\/em><\/p>\n\n\n\n Prior to the tour, our director of business development and corporate innovation Russel Cl?maco-Estardo spent some two and a half months in dialogue with the pill manufacturer\u2019s representatives in both China and the U.S. as he gradually built up an understanding of both what the company hoped to get out of the trip to California and, therefore, which Silicon Valley enterprises he should introduce it to.<\/p>\n\n\n\n \u201cI asked them what the key pain points are of their company,\u201d said Cl?maco-Estardo. \u201cMy questions revolve around what their issues are. That\u2019s when I integrate new companies and startups. Most of my programs are usually aligned to that.\u201d<\/p>\n\n\n\n Many of Cl?maco-Estardo\u2019s clients are in the manufacturing business, just like IVC. According to the consultant, it is an economic sector which is very much open to innovation and disruption.<\/p>\n\n\n\n \u201cThere are a lot of issues and a lot of technologies we can integrate,\u201d he said.<\/p>\n\n\n\n In the course of our more than 10 weeks of consultation with IVC we were able to distil the manufacturing company\u2019s long list of interests down to a concise list of priorities, each of which addressed a specific challenge facing its business.<\/p>\n\n\n\n Among the most problematic market developments for IVC is the trend toward precision medicine whereby individuals, thanks to much greater access to their own personal health data, are deciding for themselves which treatments and pills they wish to take.<\/p>\n\n\n\n This is already being seen today in younger generations.<\/p>\n\n\n\n \u201cThis is something IVC are worried about,\u201d said Cl?maco-Estardo. \u201cIn the future, with DNA, people will know what kind of vitamins they need and don\u2019t need. That\u2019s a problem for the company.<\/p>\n\n\n\n \u201cMost young people don\u2019t take vitamins anymore. Mostly older people are taking vitamins. So the mentality has shifted.\u201d<\/p>\n\n\n\n To help IVC address this issue we built a tour which included both introductions to startups operating in the precision health field and meetings at venture capital firms. This gave the vitamin maker an opportunity to explore partnerships and acquisitions which could help it keep up with and, eventually, get ahead of, the changes now taking place in its industry.<\/p>\n\n\n\n \u201cIVC met three precision medicine startups,\u201d said consultant Cl?maco-Estardo. \u201cWith two of them they actually went on to have serious conversations.\u201d<\/p>\n\n\n\n Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
Startups, on the other hand, are optimized to experiment and pivot based on feedback and collected data. However, she says, corporations and startups are but two sides of the same coin. Where corporations fall short in agility, they make up for in resources, market reach and industry knowledge. Startups too may have agility on their side but fall short in access to markets, resources and the other strengths corporations have.<\/p>\n\n\n\n The solution to faster life science innovation lies in corporations and startups collaborating more. One example of such a collaboration is the recent acquisition of Noona, a healthcare startup, by Varian, one of the largest radiation oncology treatments and software makers in the US.<\/p>\n\n\n\n Through this acquisition, Varian, previously stuck incrementally improving existing products, now has an entirely new line of products. Along these lines, Widya says, corporations need to seek out partnerships with innovative Silicon Valley startups, a move that can help them generate new capabilities without the lengthy and expensive process of creating such innovations in-house.<\/p>\n\n\n\n \u201cThe involvement of technology to support life science will enable so many more innovations, ideas and also products for the lives of many more people and patients around the world,\u201d concludes Widya, a statement that reflects the efforts of so many life science practitioners and startups.<\/p>\n\n\n\n But if this promise of a better tomorrow is to be realized, corporations must be willing to take the bold step of partnering with startups, many of which are pursuing \u201cmoonshot\u201d ideas in the hope of creating the life tools of tomorrow.<\/p>\n\n\n\n Silicon Valley Innovation Center supports this mission for a better tomorrow by helping corporations discover and partner with life science startups in Silicon Valley. To find out more about how you can visit Silicon Valley and experience, first hand, the breathtaking life science innovations emerging in the area, click here<\/a> or call us on +1 (650) 274-0214<\/a> to speak to an SVIC innovation tour specialist.<\/p>\n","post_title":"Overcoming Commercialization Challenges in Life Science Innovation","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"overcoming-commercialization-challenges-in-life-science-innovation","to_ping":"","pinged":"","post_modified":"2020-02-08 15:02:33","post_modified_gmt":"2020-02-08 23:02:33","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/overcoming-commercialization-challenges-in-life-science-innovation\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":764,"post_author":"1","post_date":"2018-04-17 14:51:00","post_date_gmt":"2018-04-17 21:51:00","post_content":"\n At Silicon Valley Innovation Center (SVIC) \u201csuccess\u201d does not simply equate to selling a client a tour of Silicon Valley. What it actually comes down to is creating a tour which enables them to find solutions to the major challenges they face in their business. <\/em>Outcomes of that sort come about not as a matter luck but rather as a result of a painstaking investigate process which involves working closely with our clients in order to elicit a clear articulation of the problems they want to solve.<\/em><\/p>\n\n\n\n An example of how this works can be seen in the case of International Vitamin Corporation (IVC), which recently toured Silicon Valley with our help.<\/em><\/p>\n\n\n\n Prior to the tour, our director of business development and corporate innovation Russel Cl?maco-Estardo spent some two and a half months in dialogue with the pill manufacturer\u2019s representatives in both China and the U.S. as he gradually built up an understanding of both what the company hoped to get out of the trip to California and, therefore, which Silicon Valley enterprises he should introduce it to.<\/p>\n\n\n\n \u201cI asked them what the key pain points are of their company,\u201d said Cl?maco-Estardo. \u201cMy questions revolve around what their issues are. That\u2019s when I integrate new companies and startups. Most of my programs are usually aligned to that.\u201d<\/p>\n\n\n\n Many of Cl?maco-Estardo\u2019s clients are in the manufacturing business, just like IVC. According to the consultant, it is an economic sector which is very much open to innovation and disruption.<\/p>\n\n\n\n \u201cThere are a lot of issues and a lot of technologies we can integrate,\u201d he said.<\/p>\n\n\n\n In the course of our more than 10 weeks of consultation with IVC we were able to distil the manufacturing company\u2019s long list of interests down to a concise list of priorities, each of which addressed a specific challenge facing its business.<\/p>\n\n\n\n Among the most problematic market developments for IVC is the trend toward precision medicine whereby individuals, thanks to much greater access to their own personal health data, are deciding for themselves which treatments and pills they wish to take.<\/p>\n\n\n\n This is already being seen today in younger generations.<\/p>\n\n\n\n \u201cThis is something IVC are worried about,\u201d said Cl?maco-Estardo. \u201cIn the future, with DNA, people will know what kind of vitamins they need and don\u2019t need. That\u2019s a problem for the company.<\/p>\n\n\n\n \u201cMost young people don\u2019t take vitamins anymore. Mostly older people are taking vitamins. So the mentality has shifted.\u201d<\/p>\n\n\n\n To help IVC address this issue we built a tour which included both introductions to startups operating in the precision health field and meetings at venture capital firms. This gave the vitamin maker an opportunity to explore partnerships and acquisitions which could help it keep up with and, eventually, get ahead of, the changes now taking place in its industry.<\/p>\n\n\n\n \u201cIVC met three precision medicine startups,\u201d said consultant Cl?maco-Estardo. \u201cWith two of them they actually went on to have serious conversations.\u201d<\/p>\n\n\n\n Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
\u201cCorporations and startups approach innovation in different ways,\u201d Widya says. In a corporate setting, many legacy structures and systems act as a limiting factor as to what innovations can be achieved. For example, a company like Johnson and Johnson can only innovate within the confines of its existing business scope.<\/p>\n\n\n\n Startups, on the other hand, are optimized to experiment and pivot based on feedback and collected data. However, she says, corporations and startups are but two sides of the same coin. Where corporations fall short in agility, they make up for in resources, market reach and industry knowledge. Startups too may have agility on their side but fall short in access to markets, resources and the other strengths corporations have.<\/p>\n\n\n\n The solution to faster life science innovation lies in corporations and startups collaborating more. One example of such a collaboration is the recent acquisition of Noona, a healthcare startup, by Varian, one of the largest radiation oncology treatments and software makers in the US.<\/p>\n\n\n\n Through this acquisition, Varian, previously stuck incrementally improving existing products, now has an entirely new line of products. Along these lines, Widya says, corporations need to seek out partnerships with innovative Silicon Valley startups, a move that can help them generate new capabilities without the lengthy and expensive process of creating such innovations in-house.<\/p>\n\n\n\n \u201cThe involvement of technology to support life science will enable so many more innovations, ideas and also products for the lives of many more people and patients around the world,\u201d concludes Widya, a statement that reflects the efforts of so many life science practitioners and startups.<\/p>\n\n\n\n But if this promise of a better tomorrow is to be realized, corporations must be willing to take the bold step of partnering with startups, many of which are pursuing \u201cmoonshot\u201d ideas in the hope of creating the life tools of tomorrow.<\/p>\n\n\n\n Silicon Valley Innovation Center supports this mission for a better tomorrow by helping corporations discover and partner with life science startups in Silicon Valley. To find out more about how you can visit Silicon Valley and experience, first hand, the breathtaking life science innovations emerging in the area, click here<\/a> or call us on +1 (650) 274-0214<\/a> to speak to an SVIC innovation tour specialist.<\/p>\n","post_title":"Overcoming Commercialization Challenges in Life Science Innovation","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"overcoming-commercialization-challenges-in-life-science-innovation","to_ping":"","pinged":"","post_modified":"2020-02-08 15:02:33","post_modified_gmt":"2020-02-08 23:02:33","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/overcoming-commercialization-challenges-in-life-science-innovation\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":764,"post_author":"1","post_date":"2018-04-17 14:51:00","post_date_gmt":"2018-04-17 21:51:00","post_content":"\n At Silicon Valley Innovation Center (SVIC) \u201csuccess\u201d does not simply equate to selling a client a tour of Silicon Valley. What it actually comes down to is creating a tour which enables them to find solutions to the major challenges they face in their business. <\/em>Outcomes of that sort come about not as a matter luck but rather as a result of a painstaking investigate process which involves working closely with our clients in order to elicit a clear articulation of the problems they want to solve.<\/em><\/p>\n\n\n\n An example of how this works can be seen in the case of International Vitamin Corporation (IVC), which recently toured Silicon Valley with our help.<\/em><\/p>\n\n\n\n Prior to the tour, our director of business development and corporate innovation Russel Cl?maco-Estardo spent some two and a half months in dialogue with the pill manufacturer\u2019s representatives in both China and the U.S. as he gradually built up an understanding of both what the company hoped to get out of the trip to California and, therefore, which Silicon Valley enterprises he should introduce it to.<\/p>\n\n\n\n \u201cI asked them what the key pain points are of their company,\u201d said Cl?maco-Estardo. \u201cMy questions revolve around what their issues are. That\u2019s when I integrate new companies and startups. Most of my programs are usually aligned to that.\u201d<\/p>\n\n\n\n Many of Cl?maco-Estardo\u2019s clients are in the manufacturing business, just like IVC. According to the consultant, it is an economic sector which is very much open to innovation and disruption.<\/p>\n\n\n\n \u201cThere are a lot of issues and a lot of technologies we can integrate,\u201d he said.<\/p>\n\n\n\n In the course of our more than 10 weeks of consultation with IVC we were able to distil the manufacturing company\u2019s long list of interests down to a concise list of priorities, each of which addressed a specific challenge facing its business.<\/p>\n\n\n\n Among the most problematic market developments for IVC is the trend toward precision medicine whereby individuals, thanks to much greater access to their own personal health data, are deciding for themselves which treatments and pills they wish to take.<\/p>\n\n\n\n This is already being seen today in younger generations.<\/p>\n\n\n\n \u201cThis is something IVC are worried about,\u201d said Cl?maco-Estardo. \u201cIn the future, with DNA, people will know what kind of vitamins they need and don\u2019t need. That\u2019s a problem for the company.<\/p>\n\n\n\n \u201cMost young people don\u2019t take vitamins anymore. Mostly older people are taking vitamins. So the mentality has shifted.\u201d<\/p>\n\n\n\n To help IVC address this issue we built a tour which included both introductions to startups operating in the precision health field and meetings at venture capital firms. This gave the vitamin maker an opportunity to explore partnerships and acquisitions which could help it keep up with and, eventually, get ahead of, the changes now taking place in its industry.<\/p>\n\n\n\n \u201cIVC met three precision medicine startups,\u201d said consultant Cl?maco-Estardo. \u201cWith two of them they actually went on to have serious conversations.\u201d<\/p>\n\n\n\n Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
\u201cCorporations and startups approach innovation in different ways,\u201d Widya says. In a corporate setting, many legacy structures and systems act as a limiting factor as to what innovations can be achieved. For example, a company like Johnson and Johnson can only innovate within the confines of its existing business scope.<\/p>\n\n\n\n Startups, on the other hand, are optimized to experiment and pivot based on feedback and collected data. However, she says, corporations and startups are but two sides of the same coin. Where corporations fall short in agility, they make up for in resources, market reach and industry knowledge. Startups too may have agility on their side but fall short in access to markets, resources and the other strengths corporations have.<\/p>\n\n\n\n The solution to faster life science innovation lies in corporations and startups collaborating more. One example of such a collaboration is the recent acquisition of Noona, a healthcare startup, by Varian, one of the largest radiation oncology treatments and software makers in the US.<\/p>\n\n\n\n Through this acquisition, Varian, previously stuck incrementally improving existing products, now has an entirely new line of products. Along these lines, Widya says, corporations need to seek out partnerships with innovative Silicon Valley startups, a move that can help them generate new capabilities without the lengthy and expensive process of creating such innovations in-house.<\/p>\n\n\n\n \u201cThe involvement of technology to support life science will enable so many more innovations, ideas and also products for the lives of many more people and patients around the world,\u201d concludes Widya, a statement that reflects the efforts of so many life science practitioners and startups.<\/p>\n\n\n\n But if this promise of a better tomorrow is to be realized, corporations must be willing to take the bold step of partnering with startups, many of which are pursuing \u201cmoonshot\u201d ideas in the hope of creating the life tools of tomorrow.<\/p>\n\n\n\n Silicon Valley Innovation Center supports this mission for a better tomorrow by helping corporations discover and partner with life science startups in Silicon Valley. To find out more about how you can visit Silicon Valley and experience, first hand, the breathtaking life science innovations emerging in the area, click here<\/a> or call us on +1 (650) 274-0214<\/a> to speak to an SVIC innovation tour specialist.<\/p>\n","post_title":"Overcoming Commercialization Challenges in Life Science Innovation","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"overcoming-commercialization-challenges-in-life-science-innovation","to_ping":"","pinged":"","post_modified":"2020-02-08 15:02:33","post_modified_gmt":"2020-02-08 23:02:33","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/overcoming-commercialization-challenges-in-life-science-innovation\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":764,"post_author":"1","post_date":"2018-04-17 14:51:00","post_date_gmt":"2018-04-17 21:51:00","post_content":"\n At Silicon Valley Innovation Center (SVIC) \u201csuccess\u201d does not simply equate to selling a client a tour of Silicon Valley. What it actually comes down to is creating a tour which enables them to find solutions to the major challenges they face in their business. <\/em>Outcomes of that sort come about not as a matter luck but rather as a result of a painstaking investigate process which involves working closely with our clients in order to elicit a clear articulation of the problems they want to solve.<\/em><\/p>\n\n\n\n An example of how this works can be seen in the case of International Vitamin Corporation (IVC), which recently toured Silicon Valley with our help.<\/em><\/p>\n\n\n\n Prior to the tour, our director of business development and corporate innovation Russel Cl?maco-Estardo spent some two and a half months in dialogue with the pill manufacturer\u2019s representatives in both China and the U.S. as he gradually built up an understanding of both what the company hoped to get out of the trip to California and, therefore, which Silicon Valley enterprises he should introduce it to.<\/p>\n\n\n\n \u201cI asked them what the key pain points are of their company,\u201d said Cl?maco-Estardo. \u201cMy questions revolve around what their issues are. That\u2019s when I integrate new companies and startups. Most of my programs are usually aligned to that.\u201d<\/p>\n\n\n\n Many of Cl?maco-Estardo\u2019s clients are in the manufacturing business, just like IVC. According to the consultant, it is an economic sector which is very much open to innovation and disruption.<\/p>\n\n\n\n \u201cThere are a lot of issues and a lot of technologies we can integrate,\u201d he said.<\/p>\n\n\n\n In the course of our more than 10 weeks of consultation with IVC we were able to distil the manufacturing company\u2019s long list of interests down to a concise list of priorities, each of which addressed a specific challenge facing its business.<\/p>\n\n\n\n Among the most problematic market developments for IVC is the trend toward precision medicine whereby individuals, thanks to much greater access to their own personal health data, are deciding for themselves which treatments and pills they wish to take.<\/p>\n\n\n\n This is already being seen today in younger generations.<\/p>\n\n\n\n \u201cThis is something IVC are worried about,\u201d said Cl?maco-Estardo. \u201cIn the future, with DNA, people will know what kind of vitamins they need and don\u2019t need. That\u2019s a problem for the company.<\/p>\n\n\n\n \u201cMost young people don\u2019t take vitamins anymore. Mostly older people are taking vitamins. So the mentality has shifted.\u201d<\/p>\n\n\n\n To help IVC address this issue we built a tour which included both introductions to startups operating in the precision health field and meetings at venture capital firms. This gave the vitamin maker an opportunity to explore partnerships and acquisitions which could help it keep up with and, eventually, get ahead of, the changes now taking place in its industry.<\/p>\n\n\n\n \u201cIVC met three precision medicine startups,\u201d said consultant Cl?maco-Estardo. \u201cWith two of them they actually went on to have serious conversations.\u201d<\/p>\n\n\n\n Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
Venture capital is best suited to fund startups that are in the process of turning theoretical innovations into commercially applicable products. Industry investors, on the other hand, have the option to do a bit of both. Because most large corporations are established businesses, they can afford to partner with both academic researchers and startups to find innovative solutions to either specific use cases or to come up with novel products.<\/p>\n\n\n\n \u201cCorporations and startups approach innovation in different ways,\u201d Widya says. In a corporate setting, many legacy structures and systems act as a limiting factor as to what innovations can be achieved. For example, a company like Johnson and Johnson can only innovate within the confines of its existing business scope.<\/p>\n\n\n\n Startups, on the other hand, are optimized to experiment and pivot based on feedback and collected data. However, she says, corporations and startups are but two sides of the same coin. Where corporations fall short in agility, they make up for in resources, market reach and industry knowledge. Startups too may have agility on their side but fall short in access to markets, resources and the other strengths corporations have.<\/p>\n\n\n\n The solution to faster life science innovation lies in corporations and startups collaborating more. One example of such a collaboration is the recent acquisition of Noona, a healthcare startup, by Varian, one of the largest radiation oncology treatments and software makers in the US.<\/p>\n\n\n\n Through this acquisition, Varian, previously stuck incrementally improving existing products, now has an entirely new line of products. Along these lines, Widya says, corporations need to seek out partnerships with innovative Silicon Valley startups, a move that can help them generate new capabilities without the lengthy and expensive process of creating such innovations in-house.<\/p>\n\n\n\n \u201cThe involvement of technology to support life science will enable so many more innovations, ideas and also products for the lives of many more people and patients around the world,\u201d concludes Widya, a statement that reflects the efforts of so many life science practitioners and startups.<\/p>\n\n\n\n But if this promise of a better tomorrow is to be realized, corporations must be willing to take the bold step of partnering with startups, many of which are pursuing \u201cmoonshot\u201d ideas in the hope of creating the life tools of tomorrow.<\/p>\n\n\n\n Silicon Valley Innovation Center supports this mission for a better tomorrow by helping corporations discover and partner with life science startups in Silicon Valley. To find out more about how you can visit Silicon Valley and experience, first hand, the breathtaking life science innovations emerging in the area, click here<\/a> or call us on +1 (650) 274-0214<\/a> to speak to an SVIC innovation tour specialist.<\/p>\n","post_title":"Overcoming Commercialization Challenges in Life Science Innovation","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"overcoming-commercialization-challenges-in-life-science-innovation","to_ping":"","pinged":"","post_modified":"2020-02-08 15:02:33","post_modified_gmt":"2020-02-08 23:02:33","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/overcoming-commercialization-challenges-in-life-science-innovation\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":764,"post_author":"1","post_date":"2018-04-17 14:51:00","post_date_gmt":"2018-04-17 21:51:00","post_content":"\n At Silicon Valley Innovation Center (SVIC) \u201csuccess\u201d does not simply equate to selling a client a tour of Silicon Valley. What it actually comes down to is creating a tour which enables them to find solutions to the major challenges they face in their business. <\/em>Outcomes of that sort come about not as a matter luck but rather as a result of a painstaking investigate process which involves working closely with our clients in order to elicit a clear articulation of the problems they want to solve.<\/em><\/p>\n\n\n\n An example of how this works can be seen in the case of International Vitamin Corporation (IVC), which recently toured Silicon Valley with our help.<\/em><\/p>\n\n\n\n Prior to the tour, our director of business development and corporate innovation Russel Cl?maco-Estardo spent some two and a half months in dialogue with the pill manufacturer\u2019s representatives in both China and the U.S. as he gradually built up an understanding of both what the company hoped to get out of the trip to California and, therefore, which Silicon Valley enterprises he should introduce it to.<\/p>\n\n\n\n \u201cI asked them what the key pain points are of their company,\u201d said Cl?maco-Estardo. \u201cMy questions revolve around what their issues are. That\u2019s when I integrate new companies and startups. Most of my programs are usually aligned to that.\u201d<\/p>\n\n\n\n Many of Cl?maco-Estardo\u2019s clients are in the manufacturing business, just like IVC. According to the consultant, it is an economic sector which is very much open to innovation and disruption.<\/p>\n\n\n\n \u201cThere are a lot of issues and a lot of technologies we can integrate,\u201d he said.<\/p>\n\n\n\n In the course of our more than 10 weeks of consultation with IVC we were able to distil the manufacturing company\u2019s long list of interests down to a concise list of priorities, each of which addressed a specific challenge facing its business.<\/p>\n\n\n\n Among the most problematic market developments for IVC is the trend toward precision medicine whereby individuals, thanks to much greater access to their own personal health data, are deciding for themselves which treatments and pills they wish to take.<\/p>\n\n\n\n This is already being seen today in younger generations.<\/p>\n\n\n\n \u201cThis is something IVC are worried about,\u201d said Cl?maco-Estardo. \u201cIn the future, with DNA, people will know what kind of vitamins they need and don\u2019t need. That\u2019s a problem for the company.<\/p>\n\n\n\n \u201cMost young people don\u2019t take vitamins anymore. Mostly older people are taking vitamins. So the mentality has shifted.\u201d<\/p>\n\n\n\n To help IVC address this issue we built a tour which included both introductions to startups operating in the precision health field and meetings at venture capital firms. This gave the vitamin maker an opportunity to explore partnerships and acquisitions which could help it keep up with and, eventually, get ahead of, the changes now taking place in its industry.<\/p>\n\n\n\n \u201cIVC met three precision medicine startups,\u201d said consultant Cl?maco-Estardo. \u201cWith two of them they actually went on to have serious conversations.\u201d<\/p>\n\n\n\n Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
\u201cIf we think about investment in innovation and science, there is the government, venture capitalists and industry investors,\u201d she says, \u201cand they each have a different timeline regarding their expectation of getting returns on their investment.\u201d Theoretical innovation research is best funded by government as their investment horizon tends to be longer.<\/p>\n\n\n\n Venture capital is best suited to fund startups that are in the process of turning theoretical innovations into commercially applicable products. Industry investors, on the other hand, have the option to do a bit of both. Because most large corporations are established businesses, they can afford to partner with both academic researchers and startups to find innovative solutions to either specific use cases or to come up with novel products.<\/p>\n\n\n\n \u201cCorporations and startups approach innovation in different ways,\u201d Widya says. In a corporate setting, many legacy structures and systems act as a limiting factor as to what innovations can be achieved. For example, a company like Johnson and Johnson can only innovate within the confines of its existing business scope.<\/p>\n\n\n\n Startups, on the other hand, are optimized to experiment and pivot based on feedback and collected data. However, she says, corporations and startups are but two sides of the same coin. Where corporations fall short in agility, they make up for in resources, market reach and industry knowledge. Startups too may have agility on their side but fall short in access to markets, resources and the other strengths corporations have.<\/p>\n\n\n\n The solution to faster life science innovation lies in corporations and startups collaborating more. One example of such a collaboration is the recent acquisition of Noona, a healthcare startup, by Varian, one of the largest radiation oncology treatments and software makers in the US.<\/p>\n\n\n\n Through this acquisition, Varian, previously stuck incrementally improving existing products, now has an entirely new line of products. Along these lines, Widya says, corporations need to seek out partnerships with innovative Silicon Valley startups, a move that can help them generate new capabilities without the lengthy and expensive process of creating such innovations in-house.<\/p>\n\n\n\n \u201cThe involvement of technology to support life science will enable so many more innovations, ideas and also products for the lives of many more people and patients around the world,\u201d concludes Widya, a statement that reflects the efforts of so many life science practitioners and startups.<\/p>\n\n\n\n But if this promise of a better tomorrow is to be realized, corporations must be willing to take the bold step of partnering with startups, many of which are pursuing \u201cmoonshot\u201d ideas in the hope of creating the life tools of tomorrow.<\/p>\n\n\n\n Silicon Valley Innovation Center supports this mission for a better tomorrow by helping corporations discover and partner with life science startups in Silicon Valley. To find out more about how you can visit Silicon Valley and experience, first hand, the breathtaking life science innovations emerging in the area, click here<\/a> or call us on +1 (650) 274-0214<\/a> to speak to an SVIC innovation tour specialist.<\/p>\n","post_title":"Overcoming Commercialization Challenges in Life Science Innovation","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"overcoming-commercialization-challenges-in-life-science-innovation","to_ping":"","pinged":"","post_modified":"2020-02-08 15:02:33","post_modified_gmt":"2020-02-08 23:02:33","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/overcoming-commercialization-challenges-in-life-science-innovation\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":764,"post_author":"1","post_date":"2018-04-17 14:51:00","post_date_gmt":"2018-04-17 21:51:00","post_content":"\n At Silicon Valley Innovation Center (SVIC) \u201csuccess\u201d does not simply equate to selling a client a tour of Silicon Valley. What it actually comes down to is creating a tour which enables them to find solutions to the major challenges they face in their business. <\/em>Outcomes of that sort come about not as a matter luck but rather as a result of a painstaking investigate process which involves working closely with our clients in order to elicit a clear articulation of the problems they want to solve.<\/em><\/p>\n\n\n\n An example of how this works can be seen in the case of International Vitamin Corporation (IVC), which recently toured Silicon Valley with our help.<\/em><\/p>\n\n\n\n Prior to the tour, our director of business development and corporate innovation Russel Cl?maco-Estardo spent some two and a half months in dialogue with the pill manufacturer\u2019s representatives in both China and the U.S. as he gradually built up an understanding of both what the company hoped to get out of the trip to California and, therefore, which Silicon Valley enterprises he should introduce it to.<\/p>\n\n\n\n \u201cI asked them what the key pain points are of their company,\u201d said Cl?maco-Estardo. \u201cMy questions revolve around what their issues are. That\u2019s when I integrate new companies and startups. Most of my programs are usually aligned to that.\u201d<\/p>\n\n\n\n Many of Cl?maco-Estardo\u2019s clients are in the manufacturing business, just like IVC. According to the consultant, it is an economic sector which is very much open to innovation and disruption.<\/p>\n\n\n\n \u201cThere are a lot of issues and a lot of technologies we can integrate,\u201d he said.<\/p>\n\n\n\n In the course of our more than 10 weeks of consultation with IVC we were able to distil the manufacturing company\u2019s long list of interests down to a concise list of priorities, each of which addressed a specific challenge facing its business.<\/p>\n\n\n\n Among the most problematic market developments for IVC is the trend toward precision medicine whereby individuals, thanks to much greater access to their own personal health data, are deciding for themselves which treatments and pills they wish to take.<\/p>\n\n\n\n This is already being seen today in younger generations.<\/p>\n\n\n\n \u201cThis is something IVC are worried about,\u201d said Cl?maco-Estardo. \u201cIn the future, with DNA, people will know what kind of vitamins they need and don\u2019t need. That\u2019s a problem for the company.<\/p>\n\n\n\n \u201cMost young people don\u2019t take vitamins anymore. Mostly older people are taking vitamins. So the mentality has shifted.\u201d<\/p>\n\n\n\n To help IVC address this issue we built a tour which included both introductions to startups operating in the precision health field and meetings at venture capital firms. This gave the vitamin maker an opportunity to explore partnerships and acquisitions which could help it keep up with and, eventually, get ahead of, the changes now taking place in its industry.<\/p>\n\n\n\n \u201cIVC met three precision medicine startups,\u201d said consultant Cl?maco-Estardo. \u201cWith two of them they actually went on to have serious conversations.\u201d<\/p>\n\n\n\n Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
Within a startup or corporate innovation setting, however, she says, research must be more disciplined and structured in pursuit of innovations with more near-term commercial viability. This disparity also means that funding structures will differ for each category. She identifies three distinct categories of funding and how each applies to the life science innovation process.<\/p>\n\n\n\n \u201cIf we think about investment in innovation and science, there is the government, venture capitalists and industry investors,\u201d she says, \u201cand they each have a different timeline regarding their expectation of getting returns on their investment.\u201d Theoretical innovation research is best funded by government as their investment horizon tends to be longer.<\/p>\n\n\n\n Venture capital is best suited to fund startups that are in the process of turning theoretical innovations into commercially applicable products. Industry investors, on the other hand, have the option to do a bit of both. Because most large corporations are established businesses, they can afford to partner with both academic researchers and startups to find innovative solutions to either specific use cases or to come up with novel products.<\/p>\n\n\n\n \u201cCorporations and startups approach innovation in different ways,\u201d Widya says. In a corporate setting, many legacy structures and systems act as a limiting factor as to what innovations can be achieved. For example, a company like Johnson and Johnson can only innovate within the confines of its existing business scope.<\/p>\n\n\n\n Startups, on the other hand, are optimized to experiment and pivot based on feedback and collected data. However, she says, corporations and startups are but two sides of the same coin. Where corporations fall short in agility, they make up for in resources, market reach and industry knowledge. Startups too may have agility on their side but fall short in access to markets, resources and the other strengths corporations have.<\/p>\n\n\n\n The solution to faster life science innovation lies in corporations and startups collaborating more. One example of such a collaboration is the recent acquisition of Noona, a healthcare startup, by Varian, one of the largest radiation oncology treatments and software makers in the US.<\/p>\n\n\n\n Through this acquisition, Varian, previously stuck incrementally improving existing products, now has an entirely new line of products. Along these lines, Widya says, corporations need to seek out partnerships with innovative Silicon Valley startups, a move that can help them generate new capabilities without the lengthy and expensive process of creating such innovations in-house.<\/p>\n\n\n\n \u201cThe involvement of technology to support life science will enable so many more innovations, ideas and also products for the lives of many more people and patients around the world,\u201d concludes Widya, a statement that reflects the efforts of so many life science practitioners and startups.<\/p>\n\n\n\n But if this promise of a better tomorrow is to be realized, corporations must be willing to take the bold step of partnering with startups, many of which are pursuing \u201cmoonshot\u201d ideas in the hope of creating the life tools of tomorrow.<\/p>\n\n\n\n Silicon Valley Innovation Center supports this mission for a better tomorrow by helping corporations discover and partner with life science startups in Silicon Valley. To find out more about how you can visit Silicon Valley and experience, first hand, the breathtaking life science innovations emerging in the area, click here<\/a> or call us on +1 (650) 274-0214<\/a> to speak to an SVIC innovation tour specialist.<\/p>\n","post_title":"Overcoming Commercialization Challenges in Life Science Innovation","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"overcoming-commercialization-challenges-in-life-science-innovation","to_ping":"","pinged":"","post_modified":"2020-02-08 15:02:33","post_modified_gmt":"2020-02-08 23:02:33","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/overcoming-commercialization-challenges-in-life-science-innovation\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":764,"post_author":"1","post_date":"2018-04-17 14:51:00","post_date_gmt":"2018-04-17 21:51:00","post_content":"\n At Silicon Valley Innovation Center (SVIC) \u201csuccess\u201d does not simply equate to selling a client a tour of Silicon Valley. What it actually comes down to is creating a tour which enables them to find solutions to the major challenges they face in their business. <\/em>Outcomes of that sort come about not as a matter luck but rather as a result of a painstaking investigate process which involves working closely with our clients in order to elicit a clear articulation of the problems they want to solve.<\/em><\/p>\n\n\n\n An example of how this works can be seen in the case of International Vitamin Corporation (IVC), which recently toured Silicon Valley with our help.<\/em><\/p>\n\n\n\n Prior to the tour, our director of business development and corporate innovation Russel Cl?maco-Estardo spent some two and a half months in dialogue with the pill manufacturer\u2019s representatives in both China and the U.S. as he gradually built up an understanding of both what the company hoped to get out of the trip to California and, therefore, which Silicon Valley enterprises he should introduce it to.<\/p>\n\n\n\n \u201cI asked them what the key pain points are of their company,\u201d said Cl?maco-Estardo. \u201cMy questions revolve around what their issues are. That\u2019s when I integrate new companies and startups. Most of my programs are usually aligned to that.\u201d<\/p>\n\n\n\n Many of Cl?maco-Estardo\u2019s clients are in the manufacturing business, just like IVC. According to the consultant, it is an economic sector which is very much open to innovation and disruption.<\/p>\n\n\n\n \u201cThere are a lot of issues and a lot of technologies we can integrate,\u201d he said.<\/p>\n\n\n\n In the course of our more than 10 weeks of consultation with IVC we were able to distil the manufacturing company\u2019s long list of interests down to a concise list of priorities, each of which addressed a specific challenge facing its business.<\/p>\n\n\n\n Among the most problematic market developments for IVC is the trend toward precision medicine whereby individuals, thanks to much greater access to their own personal health data, are deciding for themselves which treatments and pills they wish to take.<\/p>\n\n\n\n This is already being seen today in younger generations.<\/p>\n\n\n\n \u201cThis is something IVC are worried about,\u201d said Cl?maco-Estardo. \u201cIn the future, with DNA, people will know what kind of vitamins they need and don\u2019t need. That\u2019s a problem for the company.<\/p>\n\n\n\n \u201cMost young people don\u2019t take vitamins anymore. Mostly older people are taking vitamins. So the mentality has shifted.\u201d<\/p>\n\n\n\n To help IVC address this issue we built a tour which included both introductions to startups operating in the precision health field and meetings at venture capital firms. This gave the vitamin maker an opportunity to explore partnerships and acquisitions which could help it keep up with and, eventually, get ahead of, the changes now taking place in its industry.<\/p>\n\n\n\n \u201cIVC met three precision medicine startups,\u201d said consultant Cl?maco-Estardo. \u201cWith two of them they actually went on to have serious conversations.\u201d<\/p>\n\n\n\n Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
Widya explains the difference between curiosity-based research and application-based research. \u201cCuriosity-based research is mostly associated with academia, where curiosity and just freedom to imagine things, concepts, is very encouraged,\u201d she says.<\/p>\n\n\n\n Within a startup or corporate innovation setting, however, she says, research must be more disciplined and structured in pursuit of innovations with more near-term commercial viability. This disparity also means that funding structures will differ for each category. She identifies three distinct categories of funding and how each applies to the life science innovation process.<\/p>\n\n\n\n \u201cIf we think about investment in innovation and science, there is the government, venture capitalists and industry investors,\u201d she says, \u201cand they each have a different timeline regarding their expectation of getting returns on their investment.\u201d Theoretical innovation research is best funded by government as their investment horizon tends to be longer.<\/p>\n\n\n\n Venture capital is best suited to fund startups that are in the process of turning theoretical innovations into commercially applicable products. Industry investors, on the other hand, have the option to do a bit of both. Because most large corporations are established businesses, they can afford to partner with both academic researchers and startups to find innovative solutions to either specific use cases or to come up with novel products.<\/p>\n\n\n\n \u201cCorporations and startups approach innovation in different ways,\u201d Widya says. In a corporate setting, many legacy structures and systems act as a limiting factor as to what innovations can be achieved. For example, a company like Johnson and Johnson can only innovate within the confines of its existing business scope.<\/p>\n\n\n\n Startups, on the other hand, are optimized to experiment and pivot based on feedback and collected data. However, she says, corporations and startups are but two sides of the same coin. Where corporations fall short in agility, they make up for in resources, market reach and industry knowledge. Startups too may have agility on their side but fall short in access to markets, resources and the other strengths corporations have.<\/p>\n\n\n\n The solution to faster life science innovation lies in corporations and startups collaborating more. One example of such a collaboration is the recent acquisition of Noona, a healthcare startup, by Varian, one of the largest radiation oncology treatments and software makers in the US.<\/p>\n\n\n\n Through this acquisition, Varian, previously stuck incrementally improving existing products, now has an entirely new line of products. Along these lines, Widya says, corporations need to seek out partnerships with innovative Silicon Valley startups, a move that can help them generate new capabilities without the lengthy and expensive process of creating such innovations in-house.<\/p>\n\n\n\n \u201cThe involvement of technology to support life science will enable so many more innovations, ideas and also products for the lives of many more people and patients around the world,\u201d concludes Widya, a statement that reflects the efforts of so many life science practitioners and startups.<\/p>\n\n\n\n But if this promise of a better tomorrow is to be realized, corporations must be willing to take the bold step of partnering with startups, many of which are pursuing \u201cmoonshot\u201d ideas in the hope of creating the life tools of tomorrow.<\/p>\n\n\n\n Silicon Valley Innovation Center supports this mission for a better tomorrow by helping corporations discover and partner with life science startups in Silicon Valley. To find out more about how you can visit Silicon Valley and experience, first hand, the breathtaking life science innovations emerging in the area, click here<\/a> or call us on +1 (650) 274-0214<\/a> to speak to an SVIC innovation tour specialist.<\/p>\n","post_title":"Overcoming Commercialization Challenges in Life Science Innovation","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"overcoming-commercialization-challenges-in-life-science-innovation","to_ping":"","pinged":"","post_modified":"2020-02-08 15:02:33","post_modified_gmt":"2020-02-08 23:02:33","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/overcoming-commercialization-challenges-in-life-science-innovation\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":764,"post_author":"1","post_date":"2018-04-17 14:51:00","post_date_gmt":"2018-04-17 21:51:00","post_content":"\n At Silicon Valley Innovation Center (SVIC) \u201csuccess\u201d does not simply equate to selling a client a tour of Silicon Valley. What it actually comes down to is creating a tour which enables them to find solutions to the major challenges they face in their business. <\/em>Outcomes of that sort come about not as a matter luck but rather as a result of a painstaking investigate process which involves working closely with our clients in order to elicit a clear articulation of the problems they want to solve.<\/em><\/p>\n\n\n\n An example of how this works can be seen in the case of International Vitamin Corporation (IVC), which recently toured Silicon Valley with our help.<\/em><\/p>\n\n\n\n Prior to the tour, our director of business development and corporate innovation Russel Cl?maco-Estardo spent some two and a half months in dialogue with the pill manufacturer\u2019s representatives in both China and the U.S. as he gradually built up an understanding of both what the company hoped to get out of the trip to California and, therefore, which Silicon Valley enterprises he should introduce it to.<\/p>\n\n\n\n \u201cI asked them what the key pain points are of their company,\u201d said Cl?maco-Estardo. \u201cMy questions revolve around what their issues are. That\u2019s when I integrate new companies and startups. Most of my programs are usually aligned to that.\u201d<\/p>\n\n\n\n Many of Cl?maco-Estardo\u2019s clients are in the manufacturing business, just like IVC. According to the consultant, it is an economic sector which is very much open to innovation and disruption.<\/p>\n\n\n\n \u201cThere are a lot of issues and a lot of technologies we can integrate,\u201d he said.<\/p>\n\n\n\n In the course of our more than 10 weeks of consultation with IVC we were able to distil the manufacturing company\u2019s long list of interests down to a concise list of priorities, each of which addressed a specific challenge facing its business.<\/p>\n\n\n\n Among the most problematic market developments for IVC is the trend toward precision medicine whereby individuals, thanks to much greater access to their own personal health data, are deciding for themselves which treatments and pills they wish to take.<\/p>\n\n\n\n This is already being seen today in younger generations.<\/p>\n\n\n\n \u201cThis is something IVC are worried about,\u201d said Cl?maco-Estardo. \u201cIn the future, with DNA, people will know what kind of vitamins they need and don\u2019t need. That\u2019s a problem for the company.<\/p>\n\n\n\n \u201cMost young people don\u2019t take vitamins anymore. Mostly older people are taking vitamins. So the mentality has shifted.\u201d<\/p>\n\n\n\n To help IVC address this issue we built a tour which included both introductions to startups operating in the precision health field and meetings at venture capital firms. This gave the vitamin maker an opportunity to explore partnerships and acquisitions which could help it keep up with and, eventually, get ahead of, the changes now taking place in its industry.<\/p>\n\n\n\n \u201cIVC met three precision medicine startups,\u201d said consultant Cl?maco-Estardo. \u201cWith two of them they actually went on to have serious conversations.\u201d<\/p>\n\n\n\n Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
Widya explains the difference between curiosity-based research and application-based research. \u201cCuriosity-based research is mostly associated with academia, where curiosity and just freedom to imagine things, concepts, is very encouraged,\u201d she says.<\/p>\n\n\n\n Within a startup or corporate innovation setting, however, she says, research must be more disciplined and structured in pursuit of innovations with more near-term commercial viability. This disparity also means that funding structures will differ for each category. She identifies three distinct categories of funding and how each applies to the life science innovation process.<\/p>\n\n\n\n \u201cIf we think about investment in innovation and science, there is the government, venture capitalists and industry investors,\u201d she says, \u201cand they each have a different timeline regarding their expectation of getting returns on their investment.\u201d Theoretical innovation research is best funded by government as their investment horizon tends to be longer.<\/p>\n\n\n\n Venture capital is best suited to fund startups that are in the process of turning theoretical innovations into commercially applicable products. Industry investors, on the other hand, have the option to do a bit of both. Because most large corporations are established businesses, they can afford to partner with both academic researchers and startups to find innovative solutions to either specific use cases or to come up with novel products.<\/p>\n\n\n\n \u201cCorporations and startups approach innovation in different ways,\u201d Widya says. In a corporate setting, many legacy structures and systems act as a limiting factor as to what innovations can be achieved. For example, a company like Johnson and Johnson can only innovate within the confines of its existing business scope.<\/p>\n\n\n\n Startups, on the other hand, are optimized to experiment and pivot based on feedback and collected data. However, she says, corporations and startups are but two sides of the same coin. Where corporations fall short in agility, they make up for in resources, market reach and industry knowledge. Startups too may have agility on their side but fall short in access to markets, resources and the other strengths corporations have.<\/p>\n\n\n\n The solution to faster life science innovation lies in corporations and startups collaborating more. One example of such a collaboration is the recent acquisition of Noona, a healthcare startup, by Varian, one of the largest radiation oncology treatments and software makers in the US.<\/p>\n\n\n\n Through this acquisition, Varian, previously stuck incrementally improving existing products, now has an entirely new line of products. Along these lines, Widya says, corporations need to seek out partnerships with innovative Silicon Valley startups, a move that can help them generate new capabilities without the lengthy and expensive process of creating such innovations in-house.<\/p>\n\n\n\n \u201cThe involvement of technology to support life science will enable so many more innovations, ideas and also products for the lives of many more people and patients around the world,\u201d concludes Widya, a statement that reflects the efforts of so many life science practitioners and startups.<\/p>\n\n\n\n But if this promise of a better tomorrow is to be realized, corporations must be willing to take the bold step of partnering with startups, many of which are pursuing \u201cmoonshot\u201d ideas in the hope of creating the life tools of tomorrow.<\/p>\n\n\n\n Silicon Valley Innovation Center supports this mission for a better tomorrow by helping corporations discover and partner with life science startups in Silicon Valley. To find out more about how you can visit Silicon Valley and experience, first hand, the breathtaking life science innovations emerging in the area, click here<\/a> or call us on +1 (650) 274-0214<\/a> to speak to an SVIC innovation tour specialist.<\/p>\n","post_title":"Overcoming Commercialization Challenges in Life Science Innovation","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"overcoming-commercialization-challenges-in-life-science-innovation","to_ping":"","pinged":"","post_modified":"2020-02-08 15:02:33","post_modified_gmt":"2020-02-08 23:02:33","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/overcoming-commercialization-challenges-in-life-science-innovation\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":764,"post_author":"1","post_date":"2018-04-17 14:51:00","post_date_gmt":"2018-04-17 21:51:00","post_content":"\n At Silicon Valley Innovation Center (SVIC) \u201csuccess\u201d does not simply equate to selling a client a tour of Silicon Valley. What it actually comes down to is creating a tour which enables them to find solutions to the major challenges they face in their business. <\/em>Outcomes of that sort come about not as a matter luck but rather as a result of a painstaking investigate process which involves working closely with our clients in order to elicit a clear articulation of the problems they want to solve.<\/em><\/p>\n\n\n\n An example of how this works can be seen in the case of International Vitamin Corporation (IVC), which recently toured Silicon Valley with our help.<\/em><\/p>\n\n\n\n Prior to the tour, our director of business development and corporate innovation Russel Cl?maco-Estardo spent some two and a half months in dialogue with the pill manufacturer\u2019s representatives in both China and the U.S. as he gradually built up an understanding of both what the company hoped to get out of the trip to California and, therefore, which Silicon Valley enterprises he should introduce it to.<\/p>\n\n\n\n \u201cI asked them what the key pain points are of their company,\u201d said Cl?maco-Estardo. \u201cMy questions revolve around what their issues are. That\u2019s when I integrate new companies and startups. Most of my programs are usually aligned to that.\u201d<\/p>\n\n\n\n Many of Cl?maco-Estardo\u2019s clients are in the manufacturing business, just like IVC. According to the consultant, it is an economic sector which is very much open to innovation and disruption.<\/p>\n\n\n\n \u201cThere are a lot of issues and a lot of technologies we can integrate,\u201d he said.<\/p>\n\n\n\n In the course of our more than 10 weeks of consultation with IVC we were able to distil the manufacturing company\u2019s long list of interests down to a concise list of priorities, each of which addressed a specific challenge facing its business.<\/p>\n\n\n\n Among the most problematic market developments for IVC is the trend toward precision medicine whereby individuals, thanks to much greater access to their own personal health data, are deciding for themselves which treatments and pills they wish to take.<\/p>\n\n\n\n This is already being seen today in younger generations.<\/p>\n\n\n\n \u201cThis is something IVC are worried about,\u201d said Cl?maco-Estardo. \u201cIn the future, with DNA, people will know what kind of vitamins they need and don\u2019t need. That\u2019s a problem for the company.<\/p>\n\n\n\n \u201cMost young people don\u2019t take vitamins anymore. Mostly older people are taking vitamins. So the mentality has shifted.\u201d<\/p>\n\n\n\n To help IVC address this issue we built a tour which included both introductions to startups operating in the precision health field and meetings at venture capital firms. This gave the vitamin maker an opportunity to explore partnerships and acquisitions which could help it keep up with and, eventually, get ahead of, the changes now taking place in its industry.<\/p>\n\n\n\n \u201cIVC met three precision medicine startups,\u201d said consultant Cl?maco-Estardo. \u201cWith two of them they actually went on to have serious conversations.\u201d<\/p>\n\n\n\n Another major pain point for IVC is in supply chain management. With the company producing millions of pills per hour - making it the world\u2019s biggest vitamin maker - finding efficiencies in manufacturing and logistics is one of its constant preoccupations.<\/p>\n\n\n\n To help in this regard we connected IVC to Jabil, a global leader in electronics manufacturing and a big user of the latest technologies in its workflow.<\/p>\n\n\n\n Although their fields are different, the two companies still found much common ground, with Jabil now looking closely into how it can better use robotics and automation in its factories. IVC had much to learn from this as the challenges it faces are the same, with many of its production facilities still reliant on manual labour and in need of a technological upgrade.<\/p>\n\n\n\n The pill manufacturer was exposed to more potential for supply chain innovation through a meeting with Black Swan Data. It was here that IVC learned about the latest online listening tools which could save it huge sums of money. By using the data science techniques offered by Black Swan, the company would able to better predict where different vitamins would be needed at different times, thus generating the potential for big efficiencies in transport and warehousing.<\/p>\n\n\n\n The next piece of the puzzle when it came to addressing IVC\u2019s pain points was a meeting at Oracle, where we were able to connect the manufacturer with a number of top figures. IVC\u2019s interest here was in the computing giant\u2019s offerings in cloud-based supply chain management software. SVIC consultant Cl?maco-Estardo described the Oracle meeting as a \u201cgreat success\u201d, with IVC likely to expand its use of Oracle\u2019s resource management software in the near future. <\/p>\n\n\n\n At the end of their three days in Silicon Valley the IVC executives went away with a huge amount of new information. Not only had they seen the very latest technologies in action, they had also seen how those technologies could be applied to take their enterprise forward.<\/p>\n\n\n\n Their tour had taken them to global superstars like Google, Amazon and Oracle but it was sometimes the less well-known market players which proved to have the most to offer.<\/p>\n\n\n\n After all, Silicon Valley is the home of the startup. For IVC, getting a first-hand look at the work being done in fields like precision medicine by newly-minted companies was both a wake-up call and an inspiration. It provided a timely reminder that new competitors are always appearing, but also threw up unexpected avenues for potential mergers and acquisitions which could secure the future market position of the vitamin manufacturer.<\/p>\n\n\n\n Ultimately what an organization is looking for when it turns to SVIC for a tour are answers to the questions being posed by a constantly changing business landscape. <\/p>\n\n\n\n \u201cOur clients want to see some results which they can take back and work with,\u201d said Cl?maco-Estardo. \u201cThey come here with their problems and we solve them.\u201d<\/p>\n","post_title":"International Vitamin Corporation On a Problem-Solving Mission to Silicon Valley","post_excerpt":"","post_status":"publish","comment_status":"open","ping_status":"closed","post_password":"","post_name":"international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley","to_ping":"","pinged":"","post_modified":"2019-12-27 20:45:15","post_modified_gmt":"2019-12-28 04:45:15","post_content_filtered":"","post_parent":0,"guid":"https:\/\/siliconvalley.center\/blog\/international-vitamin-corporation-on-a-problem-solving-mission-to-silicon-valley\/","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_5"};
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
AiM for the cloud, not the stars<\/h2>\n\n\n\n
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
AiM for the cloud, not the stars<\/h2>\n\n\n\n
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
AiM for the cloud, not the stars<\/h2>\n\n\n\n
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
AiM for the cloud, not the stars<\/h2>\n\n\n\n
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
AiM for the cloud, not the stars<\/h2>\n\n\n\n
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
AiM for the cloud, not the stars<\/h2>\n\n\n\n
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
AiM for the cloud, not the stars<\/h2>\n\n\n\n
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
AiM for the cloud, not the stars<\/h2>\n\n\n\n
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
Disruptive data<\/h2>\n\n\n\n
AiM for the cloud, not the stars<\/h2>\n\n\n\n
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
![\"\"](\"https:\/\/siliconvalley.center\/wp-content\/uploads\/2019\/12\/vita-group.jpg\")
<\/figure><\/h3>\n\n\n\nDisruptive data<\/h2>\n\n\n\n
AiM for the cloud, not the stars<\/h2>\n\n\n\n
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
<\/figure><\/h3>\n\n\n\nDisruptive data<\/h2>\n\n\n\n
AiM for the cloud, not the stars<\/h2>\n\n\n\n
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
<\/figure><\/h3>\n\n\n\nDisruptive data<\/h2>\n\n\n\n
AiM for the cloud, not the stars<\/h2>\n\n\n\n
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
<\/figure><\/h3>\n\n\n\nDisruptive data<\/h2>\n\n\n\n
AiM for the cloud, not the stars<\/h2>\n\n\n\n
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
<\/figure><\/h3>\n\n\n\nDisruptive data<\/h2>\n\n\n\n
AiM for the cloud, not the stars<\/h2>\n\n\n\n
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
![\"\"](\"https:\/\/siliconvalley.center\/wp-content\/uploads\/2019\/12\/23215815_1506496172765349_1777181434397526808_o.jpg\")
<\/figure>\n\n\n\n<\/figure><\/h3>\n\n\n\nDisruptive data<\/h2>\n\n\n\n
AiM for the cloud, not the stars<\/h2>\n\n\n\n
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
<\/figure>\n\n\n\n<\/figure><\/h3>\n\n\n\nDisruptive data<\/h2>\n\n\n\n
AiM for the cloud, not the stars<\/h2>\n\n\n\n
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
<\/figure>\n\n\n\n<\/figure><\/h3>\n\n\n\nDisruptive data<\/h2>\n\n\n\n
AiM for the cloud, not the stars<\/h2>\n\n\n\n
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
<\/figure>\n\n\n\n<\/figure><\/h3>\n\n\n\nDisruptive data<\/h2>\n\n\n\n
AiM for the cloud, not the stars<\/h2>\n\n\n\n
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
<\/figure>\n\n\n\n<\/figure><\/h3>\n\n\n\nDisruptive data<\/h2>\n\n\n\n
AiM for the cloud, not the stars<\/h2>\n\n\n\n
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
<\/figure>\n\n\n\n<\/figure><\/h3>\n\n\n\nDisruptive data<\/h2>\n\n\n\n
AiM for the cloud, not the stars<\/h2>\n\n\n\n
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
Beyond the Tip of the Iceberg<\/h2>\n\n\n\n
<\/figure>\n\n\n\n<\/figure><\/h3>\n\n\n\nDisruptive data<\/h2>\n\n\n\n
AiM for the cloud, not the stars<\/h2>\n\n\n\n
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
Beyond the Tip of the Iceberg<\/h2>\n\n\n\n
<\/figure>\n\n\n\n<\/figure><\/h3>\n\n\n\nDisruptive data<\/h2>\n\n\n\n
AiM for the cloud, not the stars<\/h2>\n\n\n\n
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
Beyond the Tip of the Iceberg<\/h2>\n\n\n\n
<\/figure>\n\n\n\n<\/figure><\/h3>\n\n\n\nDisruptive data<\/h2>\n\n\n\n
AiM for the cloud, not the stars<\/h2>\n\n\n\n
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
Beyond the Tip of the Iceberg<\/h2>\n\n\n\n
<\/figure>\n\n\n\n<\/figure><\/h3>\n\n\n\nDisruptive data<\/h2>\n\n\n\n
AiM for the cloud, not the stars<\/h2>\n\n\n\n
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
Beyond the Tip of the Iceberg<\/h2>\n\n\n\n
<\/figure>\n\n\n\n<\/figure><\/h3>\n\n\n\nDisruptive data<\/h2>\n\n\n\n
AiM for the cloud, not the stars<\/h2>\n\n\n\n
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
Combine Startup and Corporate Strengths<\/h2>\n\n\n\n
Beyond the Tip of the Iceberg<\/h2>\n\n\n\n
<\/figure>\n\n\n\n<\/figure><\/h3>\n\n\n\nDisruptive data<\/h2>\n\n\n\n
AiM for the cloud, not the stars<\/h2>\n\n\n\n
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
Combine Startup and Corporate Strengths<\/h2>\n\n\n\n
Beyond the Tip of the Iceberg<\/h2>\n\n\n\n
<\/figure>\n\n\n\n<\/figure><\/h3>\n\n\n\nDisruptive data<\/h2>\n\n\n\n
AiM for the cloud, not the stars<\/h2>\n\n\n\n
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
Combine Startup and Corporate Strengths<\/h2>\n\n\n\n
Beyond the Tip of the Iceberg<\/h2>\n\n\n\n
<\/figure>\n\n\n\n<\/figure><\/h3>\n\n\n\nDisruptive data<\/h2>\n\n\n\n
AiM for the cloud, not the stars<\/h2>\n\n\n\n
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
Combine Startup and Corporate Strengths<\/h2>\n\n\n\n
Beyond the Tip of the Iceberg<\/h2>\n\n\n\n
<\/figure>\n\n\n\n<\/figure><\/h3>\n\n\n\nDisruptive data<\/h2>\n\n\n\n
AiM for the cloud, not the stars<\/h2>\n\n\n\n
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
Combine Startup and Corporate Strengths<\/h2>\n\n\n\n
Beyond the Tip of the Iceberg<\/h2>\n\n\n\n
<\/figure>\n\n\n\n<\/figure><\/h3>\n\n\n\nDisruptive data<\/h2>\n\n\n\n
AiM for the cloud, not the stars<\/h2>\n\n\n\n
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
\n
Latest
Apply Different Funding Approaches<\/h2>\n\n\n\n
Combine Startup and Corporate Strengths<\/h2>\n\n\n\n
Beyond the Tip of the Iceberg<\/h2>\n\n\n\n
<\/figure>\n\n\n\n<\/figure><\/h3>\n\n\n\nDisruptive data<\/h2>\n\n\n\n
AiM for the cloud, not the stars<\/h2>\n\n\n\n
<\/figure>\n\n\n\nReal solutions to real problems<\/h2>\n\n\n\n
Latest
